<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31344805</article-id>
<article-id pub-id-type="pmc">6696098</article-id>
<article-id pub-id-type="doi">10.3390/ijms20153611</article-id>
<article-id pub-id-type="publisher-id">ijms-20-03611</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mast Cells, Stress, Fear and Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Theoharides</surname>
<given-names>Theoharis C.</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-03611">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-03611">2</xref>
<xref ref-type="aff" rid="af3-ijms-20-03611">3</xref>
<xref ref-type="aff" rid="af4-ijms-20-03611">4</xref>
<xref ref-type="corresp" rid="c1-ijms-20-03611">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kavalioti</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="af5-ijms-20-03611">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsilioni</surname>
<given-names>Irene</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-03611">1</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-03611"><label>1</label>Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA</aff>
<aff id="af2-ijms-20-03611"><label>2</label>Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA</aff>
<aff id="af3-ijms-20-03611"><label>3</label>Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, MA 02111, USA</aff>
<aff id="af4-ijms-20-03611"><label>4</label>Department of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, MA 02111, USA</aff>
<aff id="af5-ijms-20-03611"><label>5</label>Graduate Program in Education, Lesley University, Cambridge, MA 02138, USA</aff>
<author-notes>
<corresp id="c1-ijms-20-03611"><label>*</label>Correspondence: <email>theoharis.theoharides@tufts.edu</email>; Tel.: +617-636-6866; Fax: +617-636-2456</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>15</issue>
<elocation-id>3611</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Autism Spectrum Disorder (ASD) is a developmental condition characterized by impaired communication and obsessive behavior that affects 1 in 59 children. ASD is expected to affect 1 in about 40 children by 2020, but there is still no distinct pathogenesis or effective treatments. Prenatal stress has been associated with higher risk of developing ASD in the offspring. Moreover, children with ASD cannot handle anxiety and respond disproportionately even to otherwise benign triggers. Stress and environmental stimuli trigger the unique immune cells, mast cells, which could then trigger microglia leading to abnormal synaptic pruning and dysfunctional neuronal connectivity. This process could alter the “fear threshold” in the amygdala and lead to an exaggerated “fight-or-flight” reaction. The combination of corticotropin-releasing hormone (CRH), secreted under stress, together with environmental stimuli could be major contributors to the pathogenesis of ASD. Recognizing these associations and preventing stimulation of mast cells and/or microglia could greatly benefit ASD patients.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>CRH</kwd>
<kwd>mast cells</kwd>
<kwd>stress</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-03611" sec-type="intro">
<title>1. Introduction</title>
<p>Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impaired communication and obsessive behaviors, affecting 1 in 59 children [<xref ref-type="bibr" rid="B1-ijms-20-03611">1</xref>,<xref ref-type="bibr" rid="B2-ijms-20-03611">2</xref>,<xref ref-type="bibr" rid="B3-ijms-20-03611">3</xref>,<xref ref-type="bibr" rid="B4-ijms-20-03611">4</xref>]. Projections suggest that ASD could reach 1 in 40 children by 2020 [<xref ref-type="bibr" rid="B5-ijms-20-03611">5</xref>]. Interestingly, there is no apparent significant association between socioeconomic status and risk of ASD [<xref ref-type="bibr" rid="B6-ijms-20-03611">6</xref>]. The lack of reliable biomarkers [<xref ref-type="bibr" rid="B7-ijms-20-03611">7</xref>], a distinct pathogenesis [<xref ref-type="bibr" rid="B8-ijms-20-03611">8</xref>] and presence of subgroups [<xref ref-type="bibr" rid="B9-ijms-20-03611">9</xref>], complicates the treatment of ASD [<xref ref-type="bibr" rid="B10-ijms-20-03611">10</xref>]. Numerous gene mutations have been reported in patients with ASD, but they explain less than 5% of the cases [<xref ref-type="bibr" rid="B11-ijms-20-03611">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-03611">12</xref>,<xref ref-type="bibr" rid="B13-ijms-20-03611">13</xref>]. Instead, epigenetic mechanisms [<xref ref-type="bibr" rid="B14-ijms-20-03611">14</xref>,<xref ref-type="bibr" rid="B15-ijms-20-03611">15</xref>,<xref ref-type="bibr" rid="B16-ijms-20-03611">16</xref>] due to immune [<xref ref-type="bibr" rid="B17-ijms-20-03611">17</xref>,<xref ref-type="bibr" rid="B18-ijms-20-03611">18</xref>,<xref ref-type="bibr" rid="B19-ijms-20-03611">19</xref>,<xref ref-type="bibr" rid="B20-ijms-20-03611">20</xref>], autoimmune [<xref ref-type="bibr" rid="B21-ijms-20-03611">21</xref>,<xref ref-type="bibr" rid="B22-ijms-20-03611">22</xref>] or inflammatory [<xref ref-type="bibr" rid="B23-ijms-20-03611">23</xref>] processes may be involved.</p>
<p>Brain inflammation [<xref ref-type="bibr" rid="B24-ijms-20-03611">24</xref>,<xref ref-type="bibr" rid="B25-ijms-20-03611">25</xref>] has been considered in the pathogenesis of neuropsychiatric disorders [<xref ref-type="bibr" rid="B26-ijms-20-03611">26</xref>,<xref ref-type="bibr" rid="B27-ijms-20-03611">27</xref>], including ASD [<xref ref-type="bibr" rid="B23-ijms-20-03611">23</xref>,<xref ref-type="bibr" rid="B28-ijms-20-03611">28</xref>]. A number of inflammatory molecules, such as interleukin 1β (IL-1β), tumor necrosis factor (TNF) and CXCL8 (IL-8), are increased in the brain and cerebrospinal fluid (CSF) of many patients with ASD [<xref ref-type="bibr" rid="B29-ijms-20-03611">29</xref>,<xref ref-type="bibr" rid="B30-ijms-20-03611">30</xref>,<xref ref-type="bibr" rid="B31-ijms-20-03611">31</xref>]. These molecules may derive from activation of microglia [<xref ref-type="bibr" rid="B32-ijms-20-03611">32</xref>,<xref ref-type="bibr" rid="B33-ijms-20-03611">33</xref>,<xref ref-type="bibr" rid="B34-ijms-20-03611">34</xref>,<xref ref-type="bibr" rid="B35-ijms-20-03611">35</xref>], responsible for innate immunity of the brain [<xref ref-type="bibr" rid="B36-ijms-20-03611">36</xref>,<xref ref-type="bibr" rid="B37-ijms-20-03611">37</xref>]. We reported that IL-1β and CXCL8 are released from cultured human microglia in response to the peptide neurotensin (NT) [<xref ref-type="bibr" rid="B38-ijms-20-03611">38</xref>].</p>
<p>Neuroinflammation in ASD [<xref ref-type="bibr" rid="B39-ijms-20-03611">39</xref>] may result from stimulation of mast cells [<xref ref-type="bibr" rid="B40-ijms-20-03611">40</xref>]. Indirect evidence for the role of mast cells in ASD comes from large epidemiological studies showing that ASD is significantly associated with atopic diseases such as allergies [<xref ref-type="bibr" rid="B41-ijms-20-03611">41</xref>,<xref ref-type="bibr" rid="B42-ijms-20-03611">42</xref>], asthma [<xref ref-type="bibr" rid="B43-ijms-20-03611">43</xref>] and eczema [<xref ref-type="bibr" rid="B44-ijms-20-03611">44</xref>], all of which involve mast cells. Moreover, we reported that the incidence of ASD is 10 times higher than the general population [<xref ref-type="bibr" rid="B45-ijms-20-03611">45</xref>] in children with mastocytosis, characterized by a greater number of hyperactive mast cells [<xref ref-type="bibr" rid="B40-ijms-20-03611">40</xref>].</p>
</sec>
<sec id="sec2-ijms-20-03611">
<title>2. Mast Cells and Neuroinflammation</title>
<p>Mast cells derive from bone marrow progenitors and mature perivascularly in all tissues [<xref ref-type="bibr" rid="B46-ijms-20-03611">46</xref>] where they are critical for the development of allergic reactions. Mast cells are also found in the brain, [<xref ref-type="bibr" rid="B47-ijms-20-03611">47</xref>] especially in the hypothalamus, thalamus and third ventricle [<xref ref-type="bibr" rid="B48-ijms-20-03611">48</xref>,<xref ref-type="bibr" rid="B49-ijms-20-03611">49</xref>,<xref ref-type="bibr" rid="B50-ijms-20-03611">50</xref>,<xref ref-type="bibr" rid="B51-ijms-20-03611">51</xref>,<xref ref-type="bibr" rid="B52-ijms-20-03611">52</xref>,<xref ref-type="bibr" rid="B53-ijms-20-03611">53</xref>,<xref ref-type="bibr" rid="B54-ijms-20-03611">54</xref>], as well as in the pineal, the pituitary and the thyroid glands [<xref ref-type="bibr" rid="B55-ijms-20-03611">55</xref>]. Mast cells regulate permeability of the blood–brain barrier (BBB) [<xref ref-type="bibr" rid="B56-ijms-20-03611">56</xref>,<xref ref-type="bibr" rid="B57-ijms-20-03611">57</xref>] and function as the “immune gate to the brain” [<xref ref-type="bibr" rid="B58-ijms-20-03611">58</xref>,<xref ref-type="bibr" rid="B59-ijms-20-03611">59</xref>].</p>
<p>Stimulated mast cells can secrete bioactive mediators [<xref ref-type="bibr" rid="B60-ijms-20-03611">60</xref>,<xref ref-type="bibr" rid="B61-ijms-20-03611">61</xref>,<xref ref-type="bibr" rid="B62-ijms-20-03611">62</xref>], utilizing different secretory pathways [<xref ref-type="bibr" rid="B63-ijms-20-03611">63</xref>]. Many of these mediators can be secreted from mast cells selectively without degranulation [<xref ref-type="bibr" rid="B64-ijms-20-03611">64</xref>]. Histamine, tryptase and TNF are pre-stored in secretory granules [<xref ref-type="bibr" rid="B65-ijms-20-03611">65</xref>,<xref ref-type="bibr" rid="B66-ijms-20-03611">66</xref>], while leukotrienes, prostaglandins, chemokines (CCXL8, CCL2) and TNF are synthesized de novo [<xref ref-type="bibr" rid="B60-ijms-20-03611">60</xref>,<xref ref-type="bibr" rid="B67-ijms-20-03611">67</xref>]. Mast cells also secrete tumor growth factor-β (TGF-β), which promotes the development of Th17 cells and mast cells can also secrete IL-17 [<xref ref-type="bibr" rid="B68-ijms-20-03611">68</xref>], themselves. Increased levels of IL-17 have been reported in serum and in immune cells from children with ASD [<xref ref-type="bibr" rid="B69-ijms-20-03611">69</xref>,<xref ref-type="bibr" rid="B70-ijms-20-03611">70</xref>]. Mast cells act as sensors of environmental and psychological stress [<xref ref-type="bibr" rid="B55-ijms-20-03611">55</xref>] secreting danger signals [<xref ref-type="bibr" rid="B71-ijms-20-03611">71</xref>] such as mitochondrial DNA (mtDNA) [<xref ref-type="bibr" rid="B72-ijms-20-03611">72</xref>], which acts as an “innate pathogen” [<xref ref-type="bibr" rid="B21-ijms-20-03611">21</xref>] that causes auto-inflammatory responses [<xref ref-type="bibr" rid="B73-ijms-20-03611">73</xref>,<xref ref-type="bibr" rid="B74-ijms-20-03611">74</xref>,<xref ref-type="bibr" rid="B75-ijms-20-03611">75</xref>], and is increased in the serum of children with ASD [<xref ref-type="bibr" rid="B76-ijms-20-03611">76</xref>]. As a result, mast cells are critical for different pathophysiological processes [<xref ref-type="bibr" rid="B77-ijms-20-03611">77</xref>], not only allergic reactions [<xref ref-type="bibr" rid="B78-ijms-20-03611">78</xref>], but also innate and acquired immunity [<xref ref-type="bibr" rid="B79-ijms-20-03611">79</xref>,<xref ref-type="bibr" rid="B80-ijms-20-03611">80</xref>], antigen presentation [<xref ref-type="bibr" rid="B81-ijms-20-03611">81</xref>,<xref ref-type="bibr" rid="B82-ijms-20-03611">82</xref>] and inflammation [<xref ref-type="bibr" rid="B60-ijms-20-03611">60</xref>,<xref ref-type="bibr" rid="B83-ijms-20-03611">83</xref>].</p>
<p>In addition to immunoglobulin E (IgE) and specific allergens, mast cells are stimulated by bacteria, drugs, foods, fungi, heavy metals, organophosphates and viruses, as well as certain neuropeptides including corticotropin-releasing hormone (CRH) [<xref ref-type="bibr" rid="B84-ijms-20-03611">84</xref>], neurotensin (NT) [<xref ref-type="bibr" rid="B85-ijms-20-03611">85</xref>,<xref ref-type="bibr" rid="B86-ijms-20-03611">86</xref>] and substance P (SP) [<xref ref-type="bibr" rid="B87-ijms-20-03611">87</xref>,<xref ref-type="bibr" rid="B88-ijms-20-03611">88</xref>]. Both NT [<xref ref-type="bibr" rid="B89-ijms-20-03611">89</xref>,<xref ref-type="bibr" rid="B90-ijms-20-03611">90</xref>] and SP [<xref ref-type="bibr" rid="B91-ijms-20-03611">91</xref>,<xref ref-type="bibr" rid="B92-ijms-20-03611">92</xref>,<xref ref-type="bibr" rid="B93-ijms-20-03611">93</xref>,<xref ref-type="bibr" rid="B94-ijms-20-03611">94</xref>] are known to participate in inflammatory processes.</p>
<p>Mediators derived from mast cells [<xref ref-type="bibr" rid="B40-ijms-20-03611">40</xref>,<xref ref-type="bibr" rid="B60-ijms-20-03611">60</xref>,<xref ref-type="bibr" rid="B83-ijms-20-03611">83</xref>] could activate microglia [<xref ref-type="bibr" rid="B38-ijms-20-03611">38</xref>,<xref ref-type="bibr" rid="B95-ijms-20-03611">95</xref>], causing localized inflammation [<xref ref-type="bibr" rid="B47-ijms-20-03611">47</xref>,<xref ref-type="bibr" rid="B96-ijms-20-03611">96</xref>,<xref ref-type="bibr" rid="B97-ijms-20-03611">97</xref>,<xref ref-type="bibr" rid="B98-ijms-20-03611">98</xref>] and leading to symptoms of ASD [<xref ref-type="bibr" rid="B39-ijms-20-03611">39</xref>]. Triggers of mast cells can reach the hypothalamus from the nasal cavity through the cribriform plexus [<xref ref-type="bibr" rid="B99-ijms-20-03611">99</xref>], or through the brain lymphatics [<xref ref-type="bibr" rid="B100-ijms-20-03611">100</xref>]. Alternatively, mast cell-derived mediators, especially cytokines [<xref ref-type="bibr" rid="B101-ijms-20-03611">101</xref>,<xref ref-type="bibr" rid="B102-ijms-20-03611">102</xref>], can increase the permeability of the gut–blood barrier [<xref ref-type="bibr" rid="B103-ijms-20-03611">103</xref>] and the BBB [<xref ref-type="bibr" rid="B57-ijms-20-03611">57</xref>,<xref ref-type="bibr" rid="B104-ijms-20-03611">104</xref>,<xref ref-type="bibr" rid="B105-ijms-20-03611">105</xref>], allowing toxins to cross into the brain, activating microglia [<xref ref-type="bibr" rid="B38-ijms-20-03611">38</xref>,<xref ref-type="bibr" rid="B95-ijms-20-03611">95</xref>] and disrupting neuronal connectivity, especially in the amygdala [<xref ref-type="bibr" rid="B39-ijms-20-03611">39</xref>,<xref ref-type="bibr" rid="B106-ijms-20-03611">106</xref>,<xref ref-type="bibr" rid="B107-ijms-20-03611">107</xref>].</p>
<p>Immune-neural connections regulate responses to environmental and infectious agents, leading to altered behavior [<xref ref-type="bibr" rid="B108-ijms-20-03611">108</xref>]. Environmental triggers have been implicated in ASD [<xref ref-type="bibr" rid="B17-ijms-20-03611">17</xref>,<xref ref-type="bibr" rid="B109-ijms-20-03611">109</xref>,<xref ref-type="bibr" rid="B110-ijms-20-03611">110</xref>,<xref ref-type="bibr" rid="B111-ijms-20-03611">111</xref>,<xref ref-type="bibr" rid="B112-ijms-20-03611">112</xref>], including air pollutants [<xref ref-type="bibr" rid="B113-ijms-20-03611">113</xref>,<xref ref-type="bibr" rid="B114-ijms-20-03611">114</xref>], and a variety of pathogens [<xref ref-type="bibr" rid="B103-ijms-20-03611">103</xref>]. In fact, many such affected children are now described as PANS (pediatric acute neuropsychiatric syndrome) [<xref ref-type="bibr" rid="B115-ijms-20-03611">115</xref>]. A special case can be made for mold and mycotoxins [<xref ref-type="bibr" rid="B116-ijms-20-03611">116</xref>,<xref ref-type="bibr" rid="B117-ijms-20-03611">117</xref>] because they are volatile and particularly difficult to detect. The prevalence of indoor mold in the US was reported to affect more than 50% of households in 1994 [<xref ref-type="bibr" rid="B118-ijms-20-03611">118</xref>], but their number is certainly higher following the recent floods in Louisiana, Puerto Rico, Texas and elsewhere in the world. Some indoor molds, including <italic>Trichoderma</italic>, <italic>Fusarium</italic>, and <italic>Stachybotrys</italic>, produce mycotoxins [<xref ref-type="bibr" rid="B119-ijms-20-03611">119</xref>,<xref ref-type="bibr" rid="B120-ijms-20-03611">120</xref>,<xref ref-type="bibr" rid="B121-ijms-20-03611">121</xref>,<xref ref-type="bibr" rid="B122-ijms-20-03611">122</xref>,<xref ref-type="bibr" rid="B123-ijms-20-03611">123</xref>,<xref ref-type="bibr" rid="B124-ijms-20-03611">124</xref>,<xref ref-type="bibr" rid="B125-ijms-20-03611">125</xref>,<xref ref-type="bibr" rid="B126-ijms-20-03611">126</xref>,<xref ref-type="bibr" rid="B127-ijms-20-03611">127</xref>] that can have as high as 300 times the concentration of spores [<xref ref-type="bibr" rid="B128-ijms-20-03611">128</xref>,<xref ref-type="bibr" rid="B129-ijms-20-03611">129</xref>,<xref ref-type="bibr" rid="B130-ijms-20-03611">130</xref>,<xref ref-type="bibr" rid="B131-ijms-20-03611">131</xref>,<xref ref-type="bibr" rid="B132-ijms-20-03611">132</xref>,<xref ref-type="bibr" rid="B133-ijms-20-03611">133</xref>]. Absorption of mycotoxins occurs through dermal contact, inhalation and ingestion [<xref ref-type="bibr" rid="B130-ijms-20-03611">130</xref>,<xref ref-type="bibr" rid="B134-ijms-20-03611">134</xref>,<xref ref-type="bibr" rid="B135-ijms-20-03611">135</xref>,<xref ref-type="bibr" rid="B136-ijms-20-03611">136</xref>,<xref ref-type="bibr" rid="B137-ijms-20-03611">137</xref>]. Mold-exposed individuals had altered neurological functions compared to controls [<xref ref-type="bibr" rid="B138-ijms-20-03611">138</xref>,<xref ref-type="bibr" rid="B139-ijms-20-03611">139</xref>,<xref ref-type="bibr" rid="B140-ijms-20-03611">140</xref>,<xref ref-type="bibr" rid="B141-ijms-20-03611">141</xref>] with mold-exposed children suffering cognitive deficits [<xref ref-type="bibr" rid="B142-ijms-20-03611">142</xref>,<xref ref-type="bibr" rid="B143-ijms-20-03611">143</xref>,<xref ref-type="bibr" rid="B144-ijms-20-03611">144</xref>]. In particular, six year old children exposed to mold-contaminated homes for over two years in the early postnatal period was associated with decreased intelligence [<xref ref-type="bibr" rid="B145-ijms-20-03611">145</xref>]. Ochratoxin A is the most common mycotoxin found in foods and water-damaged buildings, and has been associated with severe neuropsychiatric symptoms [<xref ref-type="bibr" rid="B116-ijms-20-03611">116</xref>,<xref ref-type="bibr" rid="B117-ijms-20-03611">117</xref>,<xref ref-type="bibr" rid="B128-ijms-20-03611">128</xref>,<xref ref-type="bibr" rid="B146-ijms-20-03611">146</xref>,<xref ref-type="bibr" rid="B147-ijms-20-03611">147</xref>] and neurological dysfunction [<xref ref-type="bibr" rid="B148-ijms-20-03611">148</xref>,<xref ref-type="bibr" rid="B149-ijms-20-03611">149</xref>]. Cognitive impairment appeared to be related to the length of exposure [<xref ref-type="bibr" rid="B138-ijms-20-03611">138</xref>,<xref ref-type="bibr" rid="B139-ijms-20-03611">139</xref>,<xref ref-type="bibr" rid="B140-ijms-20-03611">140</xref>,<xref ref-type="bibr" rid="B141-ijms-20-03611">141</xref>]. Even though a single mycotoxin may not be sufficient to produce any effect, it may increase susceptibility to other neurotoxic mycotoxins [<xref ref-type="bibr" rid="B150-ijms-20-03611">150</xref>,<xref ref-type="bibr" rid="B151-ijms-20-03611">151</xref>]; moreover, the combination of mycotoxins could induce toxicity at very low levels [<xref ref-type="bibr" rid="B152-ijms-20-03611">152</xref>].</p>
<p>Some studies have specifically linked mycotoxins to ASD [<xref ref-type="bibr" rid="B109-ijms-20-03611">109</xref>,<xref ref-type="bibr" rid="B110-ijms-20-03611">110</xref>,<xref ref-type="bibr" rid="B153-ijms-20-03611">153</xref>,<xref ref-type="bibr" rid="B154-ijms-20-03611">154</xref>]. In one study, boys with ASD had significantly more neurobehavioral abnormalities when exposed to mold than either non-exposed children with ASD or unrelated normotypic controls [<xref ref-type="bibr" rid="B155-ijms-20-03611">155</xref>]. A strong association was reported between levels of Ochratoxin A in urine and serum and presence of ASD [<xref ref-type="bibr" rid="B156-ijms-20-03611">156</xref>]. Another study reported that levels of Ochratoxin A, Aflatoxin M1 and Fumonisin B1 were significantly higher in serum and urine of children with ASD as compared to healthy controls [<xref ref-type="bibr" rid="B157-ijms-20-03611">157</xref>]. The effect of mycotoxins could be at least partially explained via stimulation of mast cells [<xref ref-type="bibr" rid="B158-ijms-20-03611">158</xref>,<xref ref-type="bibr" rid="B159-ijms-20-03611">159</xref>,<xref ref-type="bibr" rid="B160-ijms-20-03611">160</xref>] and/or microglia [<xref ref-type="bibr" rid="B157-ijms-20-03611">157</xref>].</p>
</sec>
<sec id="sec3-ijms-20-03611">
<title>3. Stress and the Fear Response</title>
<p>Stress adversely affects learning and motivation [<xref ref-type="bibr" rid="B161-ijms-20-03611">161</xref>,<xref ref-type="bibr" rid="B162-ijms-20-03611">162</xref>]. Infants recognize threatening images, an innate fear response programmed in the amygdala [<xref ref-type="bibr" rid="B163-ijms-20-03611">163</xref>,<xref ref-type="bibr" rid="B164-ijms-20-03611">164</xref>]. Interestingly, a recent study reported that toddlers with ASD responded less to common threatening images than normotypic controls [<xref ref-type="bibr" rid="B165-ijms-20-03611">165</xref>]. Later in life, children with ASD had no fear of dangerous situations such as crossing the street, but exhibited an exaggerated fear response to situation phobias and problem behaviors, as well as common images such as a butterfly, a fan or the sound of a toilet [<xref ref-type="bibr" rid="B166-ijms-20-03611">166</xref>,<xref ref-type="bibr" rid="B167-ijms-20-03611">167</xref>]. This reaction may possibly be rooted in a maladaptive lowering of the “fear response” [<xref ref-type="bibr" rid="B168-ijms-20-03611">168</xref>]. ASD patients are prone to stress, and their level of anxiety was strongly correlated with repetitive behaviors [<xref ref-type="bibr" rid="B169-ijms-20-03611">169</xref>]. A meta-analysis showed a significant association between the presence of anxiety disorders and ASD [<xref ref-type="bibr" rid="B170-ijms-20-03611">170</xref>]. Anxiety in children with ASD was consistent with sympathetic over-arousal, and increased hypothalamic-pituitary-adrenal (HPA) activation [<xref ref-type="bibr" rid="B171-ijms-20-03611">171</xref>,<xref ref-type="bibr" rid="B172-ijms-20-03611">172</xref>].</p>
<p>Prenatal stress has been associated with offspring exhibiting hyperactivity and behavioral disorders [<xref ref-type="bibr" rid="B173-ijms-20-03611">173</xref>]. Prenatal stress [<xref ref-type="bibr" rid="B174-ijms-20-03611">174</xref>,<xref ref-type="bibr" rid="B175-ijms-20-03611">175</xref>], including stress related to migration of pregnant mothers [<xref ref-type="bibr" rid="B176-ijms-20-03611">176</xref>], resulted in higher risk of giving birth to children with ASD. Maternal stress during pregnancy, due to sudden onset of floods, predicted at 30 months of postnatal age worse theory of mind, an important aspect of child development and successful social functioning [<xref ref-type="bibr" rid="B177-ijms-20-03611">177</xref>]. Prenatal and perinatal stress could lead to epigenetic changes [<xref ref-type="bibr" rid="B14-ijms-20-03611">14</xref>,<xref ref-type="bibr" rid="B15-ijms-20-03611">15</xref>,<xref ref-type="bibr" rid="B16-ijms-20-03611">16</xref>] in regulatory genes responsible for coping with stressful and hostile experiences [<xref ref-type="bibr" rid="B178-ijms-20-03611">178</xref>,<xref ref-type="bibr" rid="B179-ijms-20-03611">179</xref>]. One study of Danish men and women, for example, showed that prenatal and early postnatal stress was associated with increased serum levels of the pro-inflammatory cytokine IL-6 [<xref ref-type="bibr" rid="B180-ijms-20-03611">180</xref>].</p>
<p>There is extensive literature from animals and humans connecting the amygdala to social behavior [<xref ref-type="bibr" rid="B181-ijms-20-03611">181</xref>,<xref ref-type="bibr" rid="B182-ijms-20-03611">182</xref>] and to pathophysiologic responses to stress [<xref ref-type="bibr" rid="B183-ijms-20-03611">183</xref>]. Bauman and Kemper first reported neuropathologic changes postmortem in the amygdala [<xref ref-type="bibr" rid="B181-ijms-20-03611">181</xref>], known to be critical for responses to fear-inducing stimuli [<xref ref-type="bibr" rid="B184-ijms-20-03611">184</xref>,<xref ref-type="bibr" rid="B185-ijms-20-03611">185</xref>]. Children with ASD show an initial excess of neurons in the basal amygdala with a reduction in adulthood, while normal controls have fewer neurons in childhood, but a greater number in adulthood [<xref ref-type="bibr" rid="B186-ijms-20-03611">186</xref>]. These differences in brain volume and circuitry central to emotional processing may be at the root of the dysregulated “fear response” that many ASD patients exhibit [<xref ref-type="bibr" rid="B181-ijms-20-03611">181</xref>,<xref ref-type="bibr" rid="B187-ijms-20-03611">187</xref>]. Studies in non-human primates also showed that lesions in amygdala neonatally compromise emotional processing [<xref ref-type="bibr" rid="B188-ijms-20-03611">188</xref>,<xref ref-type="bibr" rid="B189-ijms-20-03611">189</xref>]. Furthermore, lesions in the amygdala generated stress-related behaviors in rhesus monkeys [<xref ref-type="bibr" rid="B182-ijms-20-03611">182</xref>]. Excitation of the nucleus amygdalae centralis in rats activated other nuclei in the amygdala via CRH and SP, leading to heightened responses and to prolonged emotional stress [<xref ref-type="bibr" rid="B190-ijms-20-03611">190</xref>]. We recently reported increased gene expression of the pro-inflammatory microRNA-155 only in the amygdala of children with ASD as compared to non-ASD controls [<xref ref-type="bibr" rid="B191-ijms-20-03611">191</xref>]. It is therefore reasonable to assure that focal inflammation in the amygdala could affect neuronal connectivity and affect behavior in children with ASD.</p>
<p>Postnatal stress–environment interactions may also affect the amygdala, especially its basolateral (BLA) and medial nuclei, both of which are involved in predator odor-induced fear in cats [<xref ref-type="bibr" rid="B192-ijms-20-03611">192</xref>]. For example, fear-induced activation of the BLA changed how the brain processes environmental stimuli in rats [<xref ref-type="bibr" rid="B193-ijms-20-03611">193</xref>]. Disruption of the inhibitory tone of the BLA via administration of the CRH analogue urocortin-1 (UCN-1) in rats led to persistent social inhibition [<xref ref-type="bibr" rid="B194-ijms-20-03611">194</xref>]. We had reported that UCN-1 stimulates cultured human mast cells [<xref ref-type="bibr" rid="B195-ijms-20-03611">195</xref>]. We also showed that NT [<xref ref-type="bibr" rid="B196-ijms-20-03611">196</xref>] and SP [<xref ref-type="bibr" rid="B197-ijms-20-03611">197</xref>] increased expression of the CRH receptor 1 (CRHR-1) on human mast cells, activation of which induces production of vascular endothelial growth factor (VEGF) without granule-stored tryptase [<xref ref-type="bibr" rid="B84-ijms-20-03611">84</xref>]. Moreover, CRH is synthesized by mast cells [<xref ref-type="bibr" rid="B198-ijms-20-03611">198</xref>] implying it could have autocrine effects [<xref ref-type="bibr" rid="B199-ijms-20-03611">199</xref>]. CRH augmented the effect of mtDNA on allergic stimulation of human cultured human mast cells [<xref ref-type="bibr" rid="B200-ijms-20-03611">200</xref>]. Furthermore, the combination of CRH and NT synergistically stimulated vascular endothelial growth factor (VEGF) secretion from human mast cells [<xref ref-type="bibr" rid="B86-ijms-20-03611">86</xref>], and induced the expression of each other’s receptors [<xref ref-type="bibr" rid="B196-ijms-20-03611">196</xref>]. Stimulation of brain mast cells by environmental, neural, immune, pathogenic or stress triggers can disrupt the normal “fear threshold” in the amygdala and the hypothalamic-pituitary-adrenal axis (HPA) [<xref ref-type="bibr" rid="B201-ijms-20-03611">201</xref>].</p>
<p>Evidence from rodents supports the possibility that environment–stress interactions trigger inflammation and affect brain regions that govern the “fear response” [<xref ref-type="bibr" rid="B202-ijms-20-03611">202</xref>,<xref ref-type="bibr" rid="B203-ijms-20-03611">203</xref>,<xref ref-type="bibr" rid="B204-ijms-20-03611">204</xref>,<xref ref-type="bibr" rid="B205-ijms-20-03611">205</xref>]. Prenatal stress was reported to decrease neuron excitability in the amygdala and social behavior in rats [<xref ref-type="bibr" rid="B206-ijms-20-03611">206</xref>]. Reproductive stress in female rats altered CRHR-1 expression in ova and its expression in the brain of the offspring [<xref ref-type="bibr" rid="B207-ijms-20-03611">207</xref>]. Pregnant rats exposed to a stressful insult and the drug terbutaline (used to arrest preterm labor) resulted in severe autism-like behavior in the offspring [<xref ref-type="bibr" rid="B208-ijms-20-03611">208</xref>]. Synergism between stress and environmental factors has been implicated at both the prenatal and the perinatal periods [<xref ref-type="bibr" rid="B209-ijms-20-03611">209</xref>]. For instance, combination of maternal immune activation (MIA) with prenatal exposure to vehicle exhaust particles in mice, led to autism-like behavior in mice [<xref ref-type="bibr" rid="B210-ijms-20-03611">210</xref>]. Maternal deprivation stress induces long-term colonic nerve–mast cell interactions in rats [<xref ref-type="bibr" rid="B211-ijms-20-03611">211</xref>]. We had reported that a brief period of restraint stress in mice led to significant increase in serum levels of IL-6, which was entirely dependent on mast cells [<xref ref-type="bibr" rid="B212-ijms-20-03611">212</xref>]. Other studies showed that stimulation of mast cells led to activation of microglia in vivo, an effect absent in mast cell deficient mice [<xref ref-type="bibr" rid="B213-ijms-20-03611">213</xref>]. A number of studies using MIA have reported increased expression of inflammatory molecules in the brain [<xref ref-type="bibr" rid="B214-ijms-20-03611">214</xref>]. However, no study to date has used mast cell deficient mice for any model of autism. It should, however, be noted that the most common model of MIA has recently come under severe scrutiny due to unaccounted effects on behavior due to caging differences [<xref ref-type="bibr" rid="B215-ijms-20-03611">215</xref>,<xref ref-type="bibr" rid="B216-ijms-20-03611">216</xref>].</p>
</sec>
<sec id="sec4-ijms-20-03611" sec-type="conclusions">
<title>4. Conclusions</title>
<p>Stimulation of brain mast cells and/or microglia by a combination of environmental and stress triggers may disrupt neuronal connectivity in the amygdala, thereby altering the normal “fear threshold” (<xref ref-type="fig" rid="ijms-20-03611-f001">Figure 1</xref>). This process could explain at least part of the pathogenesis of ASD. Identifying ways to inhibit inflammation in the amygdala may constitute a novel therapeutic approach for ASD. Treatments based on this premise may include natural molecules [<xref ref-type="bibr" rid="B217-ijms-20-03611">217</xref>], such as the flavonoid tetramethoxyluteolin, which has been reported to inhibit release of pro-inflammatory cytokines from mast cells [<xref ref-type="bibr" rid="B88-ijms-20-03611">88</xref>,<xref ref-type="bibr" rid="B218-ijms-20-03611">218</xref>,<xref ref-type="bibr" rid="B219-ijms-20-03611">219</xref>] and microglia [<xref ref-type="bibr" rid="B38-ijms-20-03611">38</xref>,<xref ref-type="bibr" rid="B220-ijms-20-03611">220</xref>].</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This research was partly supported by an Anonymous grant to T.C.T.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>T.C.T.: Conceived the concept and wrote the manuscript. M.K.: Assisted with the literature search. I.T.: Contributed references, created the figure and corrected the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BBB </td>
<td align="left" colspan="1" rowspan="1" valign="middle">blood–brain barrier</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BLA </td>
<td align="left" colspan="1" rowspan="1" valign="middle">basolateral nucleus of amygdala</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CRH </td>
<td align="left" colspan="1" rowspan="1" valign="middle">corticotropin-releasing hormone</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">HPA </td>
<td align="left" colspan="1" rowspan="1" valign="middle">hypothalamic-pituitary-adrenal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">mtDNA </td>
<td align="left" colspan="1" rowspan="1" valign="middle">mitochondrial DNA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">NT </td>
<td align="left" colspan="1" rowspan="1" valign="middle">neurotensin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">PANS</td>
<td align="left" colspan="1" rowspan="1" valign="middle">pediatric acute neuropsychiatric syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SP </td>
<td align="left" colspan="1" rowspan="1" valign="middle">substance P</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-03611">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fombonne</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Epidemiology of pervasive developmental disorders</article-title>
<source/>Pediatr. Res.
          <year>2009</year>
<volume>65</volume>
<fpage>591</fpage>
<pub-id pub-id-type="doi">10.1203/PDR.0b013e31819e7203</pub-id>
<pub-id pub-id-type="pmid">19218885</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-03611">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McPartland</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Volkmar</surname>
<given-names>F.R.</given-names>
</name>
</person-group>
<article-title>Autism and related disorders</article-title>
<source/>Handb. Clin. Neurol.
          <year>2012</year>
<volume>106</volume>
<fpage>407</fpage>
<lpage>418</lpage>
<pub-id pub-id-type="pmid">22608634</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-03611">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Autism</article-title>
<source/>Lancet
          <year>2014</year>
<volume>383</volume>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-03611">
<label>4.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention</collab>
</person-group>
<article-title>CDC Estimates 1 in 59 Children has been Identified with Autism Spectrum Disorder</article-title>
<year>2018</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/features/new-autism-data/index.html">https://www.cdc.gov/features/new-autism-data/index.html</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-04-27">(accessed on 27 April 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B5-ijms-20-03611">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leigh</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States</article-title>
<source/>J Autism. Dev. Disord.
          <year>2015</year>
<volume>12</volume>
<fpage>4135</fpage>
<lpage>4139</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-015-2521-7</pub-id>
<pub-id pub-id-type="pmid">26183723</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-03611">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durkin</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Maenner</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Baio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Imm</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Schieve</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Van Naarden</surname>
<given-names>B.K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism Spectrum Disorder Among US Children (2002-2010): Socioeconomic, Racial, and Ethnic Disparities</article-title>
<source/>Am. J. Public Health
          <year>2017</year>
<volume>107</volume>
<fpage>1818</fpage>
<lpage>1826</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.2017.304032</pub-id>
<pub-id pub-id-type="pmid">28933930</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-03611">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sarkans</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Biomarkers in autism spectrum disorder: The old and the new</article-title>
<source/>Psychopharmacology
          <year>2014</year>
<volume>231</volume>
<fpage>1201</fpage>
<lpage>1216</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-013-3290-7</pub-id>
<pub-id pub-id-type="pmid">24096533</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-03611">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Novel therapeutic targets for autism</article-title>
<source/>Trends Pharmacol. Sci.
          <year>2008</year>
<volume>29</volume>
<fpage>375</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2008.06.002</pub-id>
<pub-id pub-id-type="pmid">18606459</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-03611">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Medical comorbidities in autism: Challenges to diagnosis and treatment</article-title>
<source/>Neurotherapeutics
          <year>2010</year>
<volume>7</volume>
<fpage>320</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.nurt.2010.06.001</pub-id>
<pub-id pub-id-type="pmid">20643385</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-03611">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eissa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Al-Houqani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sadeq</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ojha</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Sasse</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sadek</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder</article-title>
<source/>Front. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>304</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2018.00304</pub-id>
<pub-id pub-id-type="pmid">29867317</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-03611">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahams</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Advances in autism genetics: On the threshold of a new neurobiology</article-title>
<source/>Nat. Rev. Genet.
          <year>2008</year>
<volume>9</volume>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2346</pub-id>
<pub-id pub-id-type="pmid">18414403</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-03611">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>State</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Gene hunting in autism spectrum disorder: On the path to precision medicine</article-title>
<source/>Lancet. Neurol.
          <year>2015</year>
<volume>11</volume>
<fpage>1109</fpage>
<lpage>1120</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(15)00044-7</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-03611">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>State</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders: From genes to neurobiology</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2015</year>
<volume>30</volume>
<fpage>92</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25464374</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-03611">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loke</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Hannan</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>The Role of Epigenetic Change in Autism Spectrum Disorders</article-title>
<source/>Front. Neurol.
          <year>2015</year>
<volume>6</volume>
<fpage>107</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2015.00107</pub-id>
<pub-id pub-id-type="pmid">26074864</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-03611">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eshraghi</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Eshraghi</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moshiree</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Epigenetics and Autism Spectrum Disorder: Is There a Correlation?</article-title>
<source/>Front. Cell. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>78</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00078</pub-id>
<pub-id pub-id-type="pmid">29636664</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-03611">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siu</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Epigenetics of Autism Spectrum Disorder</article-title>
<source/>Adv. Exp. Med. Biol.
          <year>2017</year>
<volume>978</volume>
<fpage>63</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">28523541</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-03611">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures</article-title>
<source/>Mol. Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>389</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2011.165</pub-id>
<pub-id pub-id-type="pmid">22143005</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-03611">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Careaga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The role of immune dysfunction in the pathophysiology of autism</article-title>
<source/>Brain. Behav. Immun.
          <year>2012</year>
<volume>26</volume>
<fpage>383</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2011.08.007</pub-id>
<pub-id pub-id-type="pmid">21906670</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-03611">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estes</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Immune mediators in the brain and peripheral tissues in autism spectrum disorder</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2015</year>
<volume>16</volume>
<fpage>469</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3978</pub-id>
<pub-id pub-id-type="pmid">26189694</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-03611">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Iosif</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Bregere</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring</article-title>
<source/>Biol. Psychiatry
          <year>2014</year>
<volume>75</volume>
<fpage>332</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.06.025</pub-id>
<pub-id pub-id-type="pmid">24011823</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-03611">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>The “missing link” in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells</article-title>
<source/>Autoimmun. Rev.
          <year>2013</year>
<volume>12</volume>
<fpage>1136</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2013.06.018</pub-id>
<pub-id pub-id-type="pmid">23831684</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-03611">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gesundheit</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rosenzweig</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Naor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lerer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zachor</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Prochazka</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kristt</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunological and autoimmune considerations of Autism Spectrum Disorders</article-title>
<source/>J. Autoimmun.
          <year>2013</year>
<volume>44</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaut.2013.05.005</pub-id>
<pub-id pub-id-type="pmid">23867105</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-03611">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A.B.</given-names>
</name>
</person-group>
<article-title>Focal brain inflammation and autism</article-title>
<source/>J. Neuroinflamm.
          <year>2013</year>
<volume>10</volume>
<fpage>46</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-10-46</pub-id>
<pub-id pub-id-type="pmid">23570274</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-03611">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Karagkouni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kourembanas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Perinatal stress, brain inflammation and risk of autism-Review and proposal</article-title>
<source/>BMC Pediatr.
          <year>2012</year>
<volume>12</volume>
<elocation-id>89</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2431-12-89</pub-id>
<pub-id pub-id-type="pmid">22747567</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-03611">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gressens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mallard</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults</article-title>
<source/>Ann. Neurol.
          <year>2012</year>
<volume>71</volume>
<fpage>444</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22620</pub-id>
<pub-id pub-id-type="pmid">22334391</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-03611">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Thomsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The role of the innate immune system in psychiatric disorders</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2013</year>
<volume>53</volume>
<fpage>52</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2012.10.002</pub-id>
<pub-id pub-id-type="pmid">23064447</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-03611">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chavarria</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alcocer-Varela</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Is damage in central nervous system due to inflammation?</article-title>
<source/>Autoimmun. Rev.
          <year>2004</year>
<volume>3</volume>
<fpage>251</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2003.09.006</pub-id>
<pub-id pub-id-type="pmid">15246020</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-03611">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Belle</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Sperry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ngo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghochani</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Laks</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Lopez-Aranda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kornblum</surname>
<given-names>H.I.</given-names>
</name>
</person-group>
<article-title>Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells</article-title>
<source/>Stem. Cell. Rep.
          <year>2014</year>
<volume>3</volume>
<fpage>725</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2014.09.004</pub-id>
<pub-id pub-id-type="pmid">25418720</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-03611">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerman</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Jyonouchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Milstien</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Varsou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heyes</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Cerebrospinal fluid and serum markers of inflammation in autism</article-title>
<source/>Pediatr. Neurol.
          <year>2005</year>
<volume>33</volume>
<fpage>195</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.03.014</pub-id>
<pub-id pub-id-type="pmid">16139734</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-03611">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sheikh</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.M.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Elevated immune response in the brain of autistic patients</article-title>
<source/>J. Neuroimmunol.
          <year>2009</year>
<volume>207</volume>
<fpage>111</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.12.002</pub-id>
<pub-id pub-id-type="pmid">19157572</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-03611">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsilioni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Taliou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Children with Autism Spectrum Disorders, who improved with a luteolin containing dietary formulation, show reduced serum levels of TNF and IL-6</article-title>
<source/>Transl. Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>647</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.142</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-03611">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Evidence of microglial activation in autism and its possible role in brain underconnectivity</article-title>
<source/>Neuron. Glia. Biol.
          <year>2011</year>
<volume>7</volume>
<fpage>205</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1017/S1740925X12000142</pub-id>
<pub-id pub-id-type="pmid">22874006</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-03611">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Ashar</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Moes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>West</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title>
<source/>Nat. Commun.
          <year>2014</year>
<volume>5</volume>
<fpage>5748</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id>
<pub-id pub-id-type="pmid">25494366</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-03611">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koyama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ikegaya</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Microglia in the pathogenesis of autism spectrum disorders</article-title>
<source/>Neurosci. Res.
          <year>2015</year>
<volume>100</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2015.06.005</pub-id>
<pub-id pub-id-type="pmid">26116891</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-03611">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takano</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Role of Microglia in Autism: Recent Advances</article-title>
<source/>Dev. Neurosci.
          <year>2015</year>
<volume>37</volume>
<fpage>195</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1159/000398791</pub-id>
<pub-id pub-id-type="pmid">25998072</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-03611">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Innate immunity in the central nervous system</article-title>
<source/>J. Clin. Investig.
          <year>2012</year>
<volume>122</volume>
<fpage>1164</fpage>
<lpage>1171</lpage>
<pub-id pub-id-type="doi">10.1172/JCI58644</pub-id>
<pub-id pub-id-type="pmid">22466658</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-03611">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguzzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Microglia: Scapegoat, saboteur, or something else?</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>156</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1126/science.1227901</pub-id>
<pub-id pub-id-type="pmid">23307732</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-03611">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Tsilioni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Leeman</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>7049</fpage>
<lpage>7058</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1604992113</pub-id>
<pub-id pub-id-type="pmid">27663735</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-03611">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Tsilioni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e844</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.77</pub-id>
<pub-id pub-id-type="pmid">27351598</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-03611">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Valent</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Akin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Mast Cells, Mastocytosis, and Related Disorders</article-title>
<source/>N Engl. J. Med.
          <year>2015</year>
<volume>373</volume>
<fpage>163</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra1409760</pub-id>
<pub-id pub-id-type="pmid">26154789</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-20-03611">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyall</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Asthma and Allergies in Children With Autism Spectrum Disorders: Results From the CHARGE Study</article-title>
<source/>Autism. Res.
          <year>2015</year>
<volume>8</volume>
<fpage>567</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1471</pub-id>
<pub-id pub-id-type="pmid">25722050</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-03611">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.Y.</given-names>
</name>
</person-group>
<article-title>Comorbidity of Atopic Disorders with Autism Spectrum Disorder and Attention Deficit/Hyperactivity Disord</article-title>
<source/>J. Pediatr.
          <year>2016</year>
<volume>171</volume>
<fpage>248</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2015.12.063</pub-id>
<pub-id pub-id-type="pmid">26846570</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-03611">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ertel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Whitcomb</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Co-occurrence of autism and asthma in a nationally-representative sample of children in the United States</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2014</year>
<volume>44</volume>
<fpage>3083</fpage>
<lpage>3088</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-014-2174-y</pub-id>
<pub-id pub-id-type="pmid">24997632</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-03611">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Billeci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tonacci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tartarisco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ruta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pioggia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gangemi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review</article-title>
<source/>Am. J. Clin. Dermatol.
          <year>2015</year>
<volume>16</volume>
<fpage>371</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1007/s40257-015-0145-5</pub-id>
<pub-id pub-id-type="pmid">26254000</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-03611">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders and mastocytosis</article-title>
<source/>Int. J. Immunopathol. Pharmacol.
          <year>2009</year>
<volume>22</volume>
<fpage>859</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1177/039463200902200401</pub-id>
<pub-id pub-id-type="pmid">20074449</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-03611">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galli</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Borregaard</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wynn</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils</article-title>
<source/>Nat. Immunol.
          <year>2011</year>
<volume>12</volume>
<fpage>1035</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1038/ni.2109</pub-id>
<pub-id pub-id-type="pmid">22012443</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-03611">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Panagiotidou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Mast cells, brain inflammation and autism</article-title>
<source/>Eur. J. Pharmacol.
          <year>2015</year>
<volume>778</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.086</pub-id>
<pub-id pub-id-type="pmid">25941080</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-03611">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambracht-Hall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Serotonin release from rat brain mast cells in vitro</article-title>
<source/>Neuroscience
          <year>1990</year>
<volume>39</volume>
<fpage>199</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(90)90233-T</pub-id>
<pub-id pub-id-type="pmid">1708465</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-03611">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edvinsson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cervos-Navarro</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Owman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ronnberg</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain</article-title>
<source/>Neurology
          <year>1977</year>
<volume>27</volume>
<fpage>878</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.27.9.878</pub-id>
<pub-id pub-id-type="pmid">408735</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-03611">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Aikawa</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs</article-title>
<source/>J. Exp. Med.
          <year>2001</year>
<volume>194</volume>
<fpage>71</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1084/jem.194.1.71</pub-id>
<pub-id pub-id-type="pmid">11435473</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-03611">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldschmidt</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Hough</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Glick</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Padawer</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mast cells in rat thalamus: Nuclear localization, sex difference and left-right asymmetry</article-title>
<source/>Brain Res.
          <year>1984</year>
<volume>323</volume>
<fpage>209</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(84)90291-9</pub-id>
<pub-id pub-id-type="pmid">6084538</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-03611">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taiwo</surname>
<given-names>O.B.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Unilateral spinal nerve ligation leads to an asymmetrical distribution of mast cells in the thalamus of female but not male mice</article-title>
<source/>Pain
          <year>2005</year>
<volume>114</volume>
<fpage>131</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.pain.2004.12.002</pub-id>
<pub-id pub-id-type="pmid">15733638</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-03611">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marathias</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lambracht-Hall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Savala</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Endogenous regulation of rat brain mast cell serotonin release</article-title>
<source/>Int. Arch. Allergy Appl. Immunol.
          <year>1991</year>
<volume>95</volume>
<fpage>332</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1159/000235470</pub-id>
<pub-id pub-id-type="pmid">1720423</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-03611">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Letourneau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rozniecki</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Definitive characterization of rat hypothalamic mast cells</article-title>
<source/>Neuroscience
          <year>1996</year>
<volume>73</volume>
<fpage>889</fpage>
<lpage>902</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4522(95)00606-0</pub-id>
<pub-id pub-id-type="pmid">8809807</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-03611">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Neuroendocrinology of mast cells: Challenges and controversies</article-title>
<source/>Exp. Dermatol.
          <year>2017</year>
<volume>26</volume>
<fpage>751</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1111/exd.13288</pub-id>
<pub-id pub-id-type="pmid">28094875</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-03611">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone and the blood-brain-barrier</article-title>
<source/>Front. Biosci.
          <year>2007</year>
<volume>12</volume>
<fpage>1615</fpage>
<lpage>1628</lpage>
<pub-id pub-id-type="doi">10.2741/2174</pub-id>
<pub-id pub-id-type="pmid">17127408</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-03611">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kandere-Grzybowska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tutor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress</article-title>
<source/>J. Pharmacol. Exp. Ther.
          <year>2002</year>
<volume>303</volume>
<fpage>1061</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.102.038497</pub-id>
<pub-id pub-id-type="pmid">12438528</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-03611">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Mast cells: The immune gate to the brain</article-title>
<source/>Life Sci.
          <year>1990</year>
<volume>46</volume>
<fpage>607</fpage>
<lpage>617</lpage>
<pub-id pub-id-type="doi">10.1016/0024-3205(90)90129-F</pub-id>
<pub-id pub-id-type="pmid">2407920</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-03611">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribatti</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The crucial role of mast cells in blood-brain barrier alterations</article-title>
<source/>Exp. Cell. Res.
          <year>2015</year>
<volume>338</volume>
<fpage>119</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2015.05.013</pub-id>
<pub-id pub-id-type="pmid">26004870</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-03611">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Mast cells as sources of cytokines, chemokines, and growth factors</article-title>
<source/>Immunol. Rev.
          <year>2018</year>
<volume>282</volume>
<fpage>121</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1111/imr.12634</pub-id>
<pub-id pub-id-type="pmid">29431212</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-03611">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The critical role of mast cells in allergy and inflammation</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2006</year>
<volume>1088</volume>
<fpage>78</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1366.025</pub-id>
<pub-id pub-id-type="pmid">17192558</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-03611">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wernersson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pejler</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Mast cell secretory granules: Armed for battle</article-title>
<source/>Nat. Rev. Immunol.
          <year>2014</year>
<volume>14</volume>
<fpage>478</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1038/nri3690</pub-id>
<pub-id pub-id-type="pmid">24903914</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-03611">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bin</surname>
<given-names>N.R.</given-names>
</name>
<name>
<surname>Sugita</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Diverse exocytic pathways for mast cell mediators</article-title>
<source/>Biochem. Soc. Trans.
          <year>2018</year>
<volume>46</volume>
<fpage>235</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1042/BST20170450</pub-id>
<pub-id pub-id-type="pmid">29472369</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-03611">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tagen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Differential release of mast cell mediators and the pathogenesis of inflammation</article-title>
<source/>Immunol. Rev.
          <year>2007</year>
<volume>217</volume>
<fpage>65</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00519.x</pub-id>
<pub-id pub-id-type="pmid">17498052</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-03611">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Mast cells as a source of both preformed and immunologically inducible TNF-a/cachectin</article-title>
<source/>Nature
          <year>1990</year>
<volume>346</volume>
<fpage>274</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1038/346274a0</pub-id>
<pub-id pub-id-type="pmid">2374592</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-03611">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sismanopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Delivanis</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Miniati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Katsarou-Katsari</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis</article-title>
<source/>J. Allergy Clin. Immunol.
          <year>2011</year>
<volume>127</volume>
<fpage>1522</fpage>
<lpage>1531</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2011.02.005</pub-id>
<pub-id pub-id-type="pmid">21453958</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-03611">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caraffa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kritas</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Ronconi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lessiani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Toniato</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues</article-title>
<source/>J. Biol. Regul. Homeost. Agents
          <year>2017</year>
<volume>312</volume>
<fpage>63</fpage>
<lpage>67</lpage>
</element-citation>
</ref>
<ref id="B68-ijms-20-03611">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noordenbos</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Blijdorp</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stap</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mul</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Canete</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Lubberts</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yeremenko</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baeten</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Human mast cells capture, store, and release bioactive, exogenous IL-17A</article-title>
<source/>J. Leukoc. Biol.
          <year>2016</year>
<volume>100</volume>
<fpage>453</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.3HI1215-542R</pub-id>
<pub-id pub-id-type="pmid">27034403</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-20-03611">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ayadhi</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Elevated serum levels of interleukin-17A in children with autism</article-title>
<source/>J. Neuroinflamm.
          <year>2012</year>
<volume>9</volume>
<fpage>158</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-9-158</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-03611">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akintunde</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Heuer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>W.J.</given-names>
</name>
</person-group>
<article-title>Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma</article-title>
<source/>J. Neuroimmunol.
          <year>2015</year>
<volume>286</volume>
<fpage>33</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2015.07.003</pub-id>
<pub-id pub-id-type="pmid">26298322</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-03611">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Danger Signals and Inflammation</article-title>
<source/>Clin. Ther.
          <year>2016</year>
<volume>38</volume>
<fpage>996</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2016.03.036</pub-id>
<pub-id pub-id-type="pmid">27101818</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-03611">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sismanopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e49767</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049767</pub-id>
<pub-id pub-id-type="pmid">23284625</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-20-03611">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Hajizadeh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holme</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Tarkowski</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses</article-title>
<source/>J. Leukoc. Biol.
          <year>2004</year>
<volume>75</volume>
<fpage>995</fpage>
<lpage>1000</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.0703328</pub-id>
<pub-id pub-id-type="pmid">14982943</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-20-03611">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Soriani</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>T.V.</given-names>
</name>
<name>
<surname>Melgaco</surname>
<given-names>J.G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure</article-title>
<source/>Hepatology
          <year>2012</year>
<volume>56</volume>
<fpage>1971</fpage>
<lpage>1982</lpage>
<pub-id pub-id-type="doi">10.1002/hep.25801</pub-id>
<pub-id pub-id-type="pmid">22532075</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-20-03611">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sursal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adibnia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Otterbein</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Itagaki</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>59989</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059989</pub-id>
<pub-id pub-id-type="pmid">23527291</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-20-03611">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sideri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lykouras</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children</article-title>
<source/>J. Neuroinflamm.
          <year>2010</year>
<volume>7</volume>
<fpage>80</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-7-80</pub-id>
<pub-id pub-id-type="pmid">21083929</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-20-03611">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease</article-title>
<source/>Trends Immunol.
          <year>2002</year>
<volume>23</volume>
<fpage>425</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1016/S1471-4906(02)02274-3</pub-id>
<pub-id pub-id-type="pmid">12200056</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-20-03611">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaven</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Our perception of the mast cell from Paul Ehrlich to now</article-title>
<source/>Eur. J. Immunol.
          <year>2009</year>
<volume>39</volume>
<fpage>11</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1002/eji.200838899</pub-id>
<pub-id pub-id-type="pmid">19130582</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-20-03611">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galli</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piliponsky</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>The development of allergic inflammation</article-title>
<source/>Nature
          <year>2008</year>
<volume>454</volume>
<fpage>445</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1038/nature07204</pub-id>
<pub-id pub-id-type="pmid">18650915</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-20-03611">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toniato</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Frydas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Robuffo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ronconi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Caraffa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kritas</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Activation and inhibition of adaptive immune response mediated by mast cells</article-title>
<source/>J. Biol. Regul. Homeost. Agents
          <year>2017</year>
<volume>31</volume>
<fpage>543</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="pmid">28952282</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-20-03611">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Croft</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II</article-title>
<source/>BMC Immunol.
          <year>2010</year>
<volume>11</volume>
<elocation-id>34</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2172-11-34</pub-id>
<pub-id pub-id-type="pmid">20591187</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-20-03611">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll-Portillo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cambi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lidke</surname>
<given-names>D.S.</given-names>
</name>
</person-group>
<article-title>Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation</article-title>
<source/>J. Cell. Biol.
          <year>2015</year>
<volume>210</volume>
<fpage>851</fpage>
<lpage>864</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201412074</pub-id>
<pub-id pub-id-type="pmid">26304724</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-20-03611">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Delivanis</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Sismanopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Miniati</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mast cells and inflammation</article-title>
<source/>Biochim. Biophys. Acta
          <year>2010</year>
<volume>1822</volume>
<fpage>21</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2010.12.014</pub-id>
<pub-id pub-id-type="pmid">21185371</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-20-03611">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Sugimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cetrulo</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor</article-title>
<source/>J. Immunol.
          <year>2005</year>
<volume>174</volume>
<fpage>7665</fpage>
<lpage>7675</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.174.12.7665</pub-id>
<pub-id pub-id-type="pmid">15944267</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-20-03611">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazarus</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Rivier</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Verification of both the sequence and confromational specificity of neurotensin in binding to mast cells</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>1977</year>
<volume>76</volume>
<fpage>1079</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1016/0006-291X(77)90966-4</pub-id>
<pub-id pub-id-type="pmid">901462</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-20-03611">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donelan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lytinas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Papaliodis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2006</year>
<volume>103</volume>
<fpage>7759</fpage>
<lpage>7764</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0602210103</pub-id>
<pub-id pub-id-type="pmid">16682628</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-20-03611">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoermann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gleixner</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Dinu</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Kundi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Greiner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wimazal</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hadzijusufovic</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mitterbauer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mannhalter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Valent</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease</article-title>
<source/>Allergy
          <year>2014</year>
<volume>69</volume>
<fpage>810</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="doi">10.1111/all.12409</pub-id>
<pub-id pub-id-type="pmid">24750133</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-20-03611">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells</article-title>
<source/>J. Pharmacol. Exp. Ther.
          <year>2017</year>
<volume>361</volume>
<fpage>462</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.117.240564</pub-id>
<pub-id pub-id-type="pmid">28404689</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-20-03611">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustain</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Rychahou</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Evers</surname>
<given-names>B.M.</given-names>
</name>
</person-group>
<article-title>The role of neurotensin in physiologic and pathologic processes</article-title>
<source/>Curr. Opin. Endocrinol. Diabetes Obes.
          <year>2011</year>
<volume>18</volume>
<fpage>75</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1097/MED.0b013e3283419052</pub-id>
<pub-id pub-id-type="pmid">21124211</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-20-03611">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caceda</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kinkead</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nemeroff</surname>
<given-names>C.B.</given-names>
</name>
</person-group>
<article-title>Neurotensin: Role in psychiatric and neurological diseases</article-title>
<source/>Peptides
          <year>2006</year>
<volume>27</volume>
<fpage>2385</fpage>
<lpage>2404</lpage>
<pub-id pub-id-type="doi">10.1016/j.peptides.2006.04.024</pub-id>
<pub-id pub-id-type="pmid">16891042</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-20-03611">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mashaghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marmalidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tehrani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Pothoulakis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dana</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neuropeptide substance P and the immune response</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2016</year>
<volume>73</volume>
<fpage>4249</fpage>
<lpage>4264</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-016-2293-z</pub-id>
<pub-id pub-id-type="pmid">27314883</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-20-03611">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Connor</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>O’Connell</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Goode</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bredin</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The role of substance P in inflammatory disease</article-title>
<source/>J. Cell. Physiol.
          <year>2004</year>
<volume>201</volume>
<fpage>167</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.20061</pub-id>
<pub-id pub-id-type="pmid">15334652</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-20-03611">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hokfelt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pernow</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wahren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Substance</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>A pioneer amongst neuropeptides</article-title>
<source/>J. Intern. Med.
          <year>2001</year>
<volume>249</volume>
<fpage>27</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1046/j.0954-6820.2000.00773.x</pub-id>
<pub-id pub-id-type="pmid">11168782</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-20-03611">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douglas</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Leeman</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Neurokinin-1 receptor: Functional significance in the immune system in reference to selected infections and inflammation</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2011</year>
<volume>1217</volume>
<fpage>83</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05826.x</pub-id>
<pub-id pub-id-type="pmid">21091716</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-20-03611">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Induction of Microglial Activation by Mediators Released from Mast Cells</article-title>
<source/>Cell. Physiol. Biochem.
          <year>2016</year>
<volume>38</volume>
<fpage>1520</fpage>
<lpage>1531</lpage>
<pub-id pub-id-type="doi">10.1159/000443093</pub-id>
<pub-id pub-id-type="pmid">27050634</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-20-03611">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skaper</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Facci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giusti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: A review</article-title>
<source/>CNS Neurol. Disord. Drug Targets
          <year>2014</year>
<volume>13</volume>
<fpage>1654</fpage>
<lpage>1666</lpage>
<pub-id pub-id-type="doi">10.2174/1871527313666141130224206</pub-id>
<pub-id pub-id-type="pmid">25470401</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-20-03611">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girolamo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ribatti</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases</article-title>
<source/>Brain Behav. Immun.
          <year>2017</year>
<volume>65</volume>
<fpage>68</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2017.06.017</pub-id>
<pub-id pub-id-type="pmid">28676349</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-20-03611">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Hatziagelaki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kolaitis</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Brain “fog,” inflammation and obesity: Key aspects of 2 neuropsychiatric disorders improved by luteolin</article-title>
<source/>Front. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>225</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2015.00225</pub-id>
<pub-id pub-id-type="pmid">26190965</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-20-03611">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Syrigou</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Makris</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stavrianeas</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis</article-title>
<source/>Ann. Allergy Asthma Immunol.
          <year>2007</year>
<volume>98</volume>
<fpage>269</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1016/S1081-1206(10)60717-X</pub-id>
<pub-id pub-id-type="pmid">17378259</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-20-03611">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louveau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Smirnov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Keyes</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Eccles</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Rouhani</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Peske</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Derecki</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Castle</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural and functional features of central nervous system lymphatic vessels</article-title>
<source/>Nature
          <year>2015</year>
<volume>523</volume>
<fpage>337</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1038/nature14432</pub-id>
<pub-id pub-id-type="pmid">26030524</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-20-03611">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbott</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Inflammatory mediators and modulation of blood-brain barrier permeability</article-title>
<source/>Cell. Mol. Neurobiol.
          <year>2000</year>
<volume>20</volume>
<fpage>131</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1023/A:1007074420772</pub-id>
<pub-id pub-id-type="pmid">10696506</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-20-03611">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Hsuchou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Manda</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kastin</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Cytokine signaling modulates blood-brain barrier function</article-title>
<source/>Curr. Pharm. Des.
          <year>2011</year>
<volume>17</volume>
<fpage>3729</fpage>
<lpage>3740</lpage>
<pub-id pub-id-type="doi">10.2174/138161211798220918</pub-id>
<pub-id pub-id-type="pmid">21834767</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-20-03611">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srikantha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mohajeri</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>2115</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20092115</pub-id>
<pub-id pub-id-type="pmid">31035684</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-20-03611">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Autism, gut-blood-brain barrier and mast cells</article-title>
<source/>J. Clin. Psychopharm.
          <year>2008</year>
<volume>28</volume>
<fpage>479</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1097/JCP.0b013e3181845f48</pub-id>
<pub-id pub-id-type="pmid">18794641</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-20-03611">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorentino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sapone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Senger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Camhi</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Kadzielski</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Buie</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Cascella</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fasano</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders</article-title>
<source/>Mol. Autism.
          <year>2016</year>
<volume>7</volume>
<fpage>49</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-016-0110-z</pub-id>
<pub-id pub-id-type="pmid">27957319</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-20-03611">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozniecki</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Sahagian</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Acute restraint stress induces brain metastases of luciferase-tagged breast cancer cells in mice</article-title>
<source/>Brain Behav. Immun.
          <year>2009</year>
<volume>1366</volume>
<fpage>204</fpage>
<lpage>210</lpage>
</element-citation>
</ref>
<ref id="B107-ijms-20-03611">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cowan</surname>
<given-names>C.S.M.</given-names>
</name>
<name>
<surname>Hoban</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Ventura-Silva</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling</article-title>
<source/>Bioessays
          <year>2018</year>
<volume>40</volume>
<fpage>1700172</fpage>
<pub-id pub-id-type="doi">10.1002/bies.201700172</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-20-03611">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCusker</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>K.W.</given-names>
</name>
</person-group>
<article-title>Immune-neural connections: How the immune system’s response to infectious agents influences behavior</article-title>
<source/>J. Exp. Biol.
          <year>2013</year>
<volume>216</volume>
<fpage>84</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1242/jeb.073411</pub-id>
<pub-id pub-id-type="pmid">23225871</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-20-03611">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders</article-title>
<source/>Curr. Opin. Neurol.
          <year>2010</year>
<volume>23</volume>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0b013e328336a01f</pub-id>
<pub-id pub-id-type="pmid">20087183</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-20-03611">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deth</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Muratore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Benzecry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Power-Charnitsky</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Waly</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis</article-title>
<source/>NeuroToxicology
          <year>2008</year>
<volume>29</volume>
<fpage>190</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2007.09.010</pub-id>
<pub-id pub-id-type="pmid">18031821</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-20-03611">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sealey</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Sriskanda</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Johnson-Williams</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Bagasra</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Environmental factors in the development of autism spectrum disorders</article-title>
<source/>Environ. Int.
          <year>2016</year>
<volume>88</volume>
<fpage>288</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1016/j.envint.2015.12.021</pub-id>
<pub-id pub-id-type="pmid">26826339</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-20-03611">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Modabbernia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Velthorst</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reichenberg</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Environmental risk factors for autism: An evidence-based review of systematic reviews and meta-analyses</article-title>
<source/>Mol. Autism.
          <year>2017</year>
<volume>8</volume>
<fpage>13</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0121-4</pub-id>
<pub-id pub-id-type="pmid">28331572</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-20-03611">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCall</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Childhood IQ’s as Predictors of Adult Educational and Occupational Status</article-title>
<source/>Science
          <year>1977</year>
<volume>197</volume>
<fpage>482</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="doi">10.1126/science.197.4302.482</pub-id>
<pub-id pub-id-type="pmid">17783247</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-20-03611">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moffitt</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Gabrielli</surname>
<given-names>W.F.</given-names>
</name>
<name>
<surname>Mednick</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Schulsinger</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Socioeconomic status, IQ, and delinquency</article-title>
<source/>J. Abnorm. Psychol.
          <year>1981</year>
<volume>90</volume>
<fpage>152</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1037/0021-843X.90.2.152</pub-id>
<pub-id pub-id-type="pmid">7288005</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-20-03611">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Frankovich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cooperstock</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Latimer</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Pasternack</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Thienemann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference</article-title>
<source/>J. Child Adolesc. Psychopharmacol.
          <year>2015</year>
<volume>25</volume>
<fpage>3</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1089/cap.2014.0084</pub-id>
<pub-id pub-id-type="pmid">25325534</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-20-03611">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Mold and Immunity</article-title>
<source/>Clin. Ther.
          <year>2018</year>
<volume>40</volume>
<fpage>882</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2018.05.005</pub-id>
<pub-id pub-id-type="pmid">29859636</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-20-03611">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ratnaseelan</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Tsilioni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes</article-title>
<source/>Clin. Ther.
          <year>2018</year>
<volume>40</volume>
<fpage>903</fpage>
<lpage>917</lpage>
<pub-id pub-id-type="doi">10.1016/j.clinthera.2018.05.004</pub-id>
<pub-id pub-id-type="pmid">29880330</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-20-03611">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spengler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neas</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dockery</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Speizer</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raizenne</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Respiratory symptoms and housing characteristics</article-title>
<source/>Indoor Air
          <year>1994</year>
<volume>4</volume>
<fpage>72</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0668.1994.t01-2-00002.x</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-20-03611">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismaiel</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Papenbrock</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mycotoxins: Producing Fungi and Mechanisms of Phytotoxicity</article-title>
<source/>Agriculture
          <year>2015</year>
<volume>5</volume>
<fpage>492</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.3390/agriculture5030492</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-20-03611">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocha</surname>
<given-names>M.E.B.</given-names>
</name>
<name>
<surname>Chagas</surname>
<given-names>O.F.</given-names>
</name>
<name>
<surname>Maia</surname>
<given-names>F.E.F.</given-names>
</name>
<name>
<surname>Guedes</surname>
<given-names>M.I.F.</given-names>
</name>
<name>
<surname>Rondina</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Mycotoxins and their effects on human and animal health</article-title>
<source/>Food Control
          <year>2014</year>
<volume>36</volume>
<fpage>159</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.foodcont.2013.08.021</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-20-03611">
<label>121.</label>
<element-citation publication-type="journal">
<article-title>American Academy of Pediatrics, Committee on Environmental Health Toxic effects of indoor molds</article-title>
<source/>Pediatrics
          <year>1998</year>
<volume>101</volume>
<fpage>712</fpage>
<lpage>714</lpage>
<pub-id pub-id-type="doi">10.1542/peds.101.4.712</pub-id>
<pub-id pub-id-type="pmid">9521963</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-20-03611">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Nikulin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koljalg</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Rainey</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reijula</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hintikka</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Salkinoja-Salonen</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Bacteria, molds, and toxins in water-damaged building materials</article-title>
<source/>Appl. Environ. Microbiol.
          <year>1997</year>
<volume>63</volume>
<fpage>387</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="pmid">9023919</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-20-03611">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peltola</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Haahtela</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mussalo-Rauhamaa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rainey</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Kroppenstedt</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Samson</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Salkinoja-Salonen</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Toxic-metabolite-producing bacteria and fungus in an indoor environment</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2001</year>
<volume>67</volume>
<fpage>3269</fpage>
<lpage>3274</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.67.7.3269-3274.2001</pub-id>
<pub-id pub-id-type="pmid">11425751</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-20-03611">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etzel</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Mycotoxins</article-title>
<source/>JAMA
          <year>2002</year>
<volume>287</volume>
<fpage>425</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1001/jama.287.4.425</pub-id>
<pub-id pub-id-type="pmid">11798344</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-20-03611">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fog</surname>
<given-names>N.K.</given-names>
</name>
</person-group>
<article-title>Mycotoxin production by indoor molds</article-title>
<source/>Fungal Genet. Biol.
          <year>2003</year>
<volume>39</volume>
<fpage>103</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">12781669</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-20-03611">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorny</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Reponen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Willeke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Robine</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Boissier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grinshpun</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Fungal fragments as indoor air biocontaminants</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2002</year>
<volume>68</volume>
<fpage>3522</fpage>
<lpage>3531</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.68.7.3522-3531.2002</pub-id>
<pub-id pub-id-type="pmid">12089037</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-20-03611">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bennett</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Klich</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mycotoxins</article-title>
<source/>Clin. Microbiol. Rev.
          <year>2003</year>
<volume>16</volume>
<fpage>497</fpage>
<lpage>516</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.16.3.497-516.2003</pub-id>
<pub-id pub-id-type="pmid">12857779</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-20-03611">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hope</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins</article-title>
<source/>Sci. World J.
          <year>2013</year>
<volume>2013</volume>
<fpage>767482</fpage>
<pub-id pub-id-type="doi">10.1155/2013/767482</pub-id>
<pub-id pub-id-type="pmid">23710148</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-20-03611">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brasel</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2005</year>
<volume>71</volume>
<fpage>114</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.71.1.114-122.2005</pub-id>
<pub-id pub-id-type="pmid">15640178</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-20-03611">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brasel</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Carriker</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins in the indoor environment</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2005</year>
<volume>71</volume>
<fpage>7376</fpage>
<lpage>7388</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.71.11.7376-7388.2005</pub-id>
<pub-id pub-id-type="pmid">16269780</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-20-03611">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charpin-Kadouch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maurel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Felipo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Queralt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ramadour</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dumon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Garans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Botta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Charpin</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Mycotoxin identification in moldy dwellings</article-title>
<source/>J. Appl. Toxicol.
          <year>2006</year>
<volume>26</volume>
<fpage>475</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="doi">10.1002/jat.1164</pub-id>
<pub-id pub-id-type="pmid">17080403</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-20-03611">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sava</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Reunova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Velasquez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harbison</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sanchez-Ramos</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Acute neurotoxic effects of the fungal metabolite ochratoxin-A</article-title>
<source/>NeuroToxicology
          <year>2006</year>
<volume>27</volume>
<fpage>82</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2005.07.004</pub-id>
<pub-id pub-id-type="pmid">16140385</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-20-03611">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sava</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Reunova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Velasquez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanchez-Ramos</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Can low level exposure to ochratoxin-A cause parkinsonism?</article-title>
<source/>J. Neurol. Sci.
          <year>2006</year>
<volume>249</volume>
<fpage>68</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2006.06.006</pub-id>
<pub-id pub-id-type="pmid">16844142</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-20-03611">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fromme</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gareis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Volkel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gottschalk</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Overall internal exposure to mycotoxins and their occurrence in occupational and residential settings–An overview</article-title>
<source/>Int. J. Hyg. Environ. Health
          <year>2016</year>
<volume>219</volume>
<fpage>143</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijheh.2015.11.004</pub-id>
<pub-id pub-id-type="pmid">26725999</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-20-03611">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziats</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Grosvenor</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Rennert</surname>
<given-names>O.M.</given-names>
</name>
</person-group>
<article-title>Functional genomics of human brain development and implications for autism spectrum disorders</article-title>
<source/>Transl. Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>665</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.153</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-20-03611">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hendry</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>A review of mycotoxins in indoor air</article-title>
<source/>J. Toxicol. Environ. Health
          <year>1993</year>
<volume>38</volume>
<fpage>183</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1080/15287399309531711</pub-id>
<pub-id pub-id-type="pmid">8433402</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-20-03611">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brasel</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Demers</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vojdani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments</article-title>
<source/>Arch. Environ. Health
          <year>2004</year>
<volume>59</volume>
<fpage>317</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.3200/AEOH.58.6.317-323</pub-id>
<pub-id pub-id-type="pmid">16238166</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-20-03611">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Thrasher</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Vojdani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mold and mycotoxins: Effects on the neurological and immune systems in humans</article-title>
<source/>Adv. Appl. Microbiol.
          <year>2004</year>
<volume>55</volume>
<fpage>375</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">15350803</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-20-03611">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crago</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Thrasher</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Psychological, neuropsychological, and electrocortical effects of mixed mold exposure</article-title>
<source/>Arch. Environ. Health
          <year>2003</year>
<volume>58</volume>
<fpage>452</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="doi">10.3200/AEOH.58.8.452-463</pub-id>
<pub-id pub-id-type="pmid">15259424</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-20-03611">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldo</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ruff</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neuropsychological performance of patients following mold exposure</article-title>
<source/>Appl. Neuropsychol.
          <year>2002</year>
<volume>9</volume>
<fpage>193</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1207/S15324826AN0904_1</pub-id>
<pub-id pub-id-type="pmid">12584073</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-20-03611">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Lockwood</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Sonawane</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Neurodegenerative diseases: An overview of environmental risk factors</article-title>
<source/>Environ. Health Perspect.
          <year>2005</year>
<volume>113</volume>
<fpage>1250</fpage>
<lpage>1256</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.7567</pub-id>
<pub-id pub-id-type="pmid">16140637</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-20-03611">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Johanning</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Charatz</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Ashman</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Breeze</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abramowitz</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cognitive impairment associated with toxigenic fungal exposure: A replication and extension of previous findings</article-title>
<source/>Appl. Neuropsychol.
          <year>2004</year>
<volume>11</volume>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1207/s15324826an1102_1</pub-id>
<pub-id pub-id-type="pmid">15477176</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-20-03611">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Torrent</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zock</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Doekes</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Forns</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guxens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taubel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sunyer</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Early life exposures to home dampness, pet ownership and farm animal contact and neuropsychological development in 4 year old children: A prospective birth cohort study</article-title>
<source/>Int. J. Hyg. Environ. Health
          <year>2013</year>
<volume>216</volume>
<fpage>690</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijheh.2012.12.013</pub-id>
<pub-id pub-id-type="pmid">23357052</pub-id>
</element-citation>
</ref>
<ref id="B144-ijms-20-03611">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anyanwu</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Vojdani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neurophysiological effects of chronic indoor environmental toxic mold exposure on children</article-title>
<source/>Sci. World J.
          <year>2003</year>
<volume>3</volume>
<fpage>281</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="doi">10.1100/tsw.2003.22</pub-id>
<pub-id pub-id-type="pmid">12806113</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-20-03611">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jedrychowski</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Maugeri</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stigter</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jankowski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Butscher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mroz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Flak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Skarupa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sowa</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cognitive function of 6-year old children exposed to mold-contaminated homes in early postnatal period. Prospective birth cohort study in Poland</article-title>
<source/>Physiol. Behav.
          <year>2011</year>
<volume>104</volume>
<fpage>989</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2011.06.019</pub-id>
<pub-id pub-id-type="pmid">21763705</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-20-03611">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Uetsuka</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways</article-title>
<source/>Int. J. Mol. Sci.
          <year>2011</year>
<volume>12</volume>
<fpage>5213</fpage>
<lpage>5237</lpage>
<pub-id pub-id-type="doi">10.3390/ijms12085213</pub-id>
<pub-id pub-id-type="pmid">21954354</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-20-03611">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Thrasher</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Vojdani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings</article-title>
<source/>Arch. Environ. Health
          <year>2003</year>
<volume>58</volume>
<fpage>464</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.3200/AEOH.58.8.464-474</pub-id>
<pub-id pub-id-type="pmid">15259425</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-20-03611">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rea</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Didriksen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fenyves</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Effects of toxic exposure to molds and mycotoxins in building-related illnesses</article-title>
<source/>Arch. Environ. Health
          <year>2003</year>
<volume>58</volume>
<fpage>399</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1080/00039896.2003.11879140</pub-id>
<pub-id pub-id-type="pmid">15143852</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-20-03611">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilburn</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Indoor mold exposure associated with neurobehavioral and pulmonary impairment: A preliminary report</article-title>
<source/>Arch. Environ. Health
          <year>2003</year>
<volume>58</volume>
<fpage>390</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1080/00039896.2003.11879139</pub-id>
<pub-id pub-id-type="pmid">15143851</pub-id>
</element-citation>
</ref>
<ref id="B150-ijms-20-03611">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karunasena</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Larranaga</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Simoni</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Building-associated neurological damage modeled in human cells: A mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment</article-title>
<source/>Mycopathologia
          <year>2010</year>
<volume>170</volume>
<fpage>377</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-010-9330-5</pub-id>
<pub-id pub-id-type="pmid">20549560</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-20-03611">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thrasher</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The biocontaminants and complexity of damp indoor spaces: More than what meets the eyes</article-title>
<source/>Toxicol. Ind. Health
          <year>2009</year>
<volume>25</volume>
<fpage>583</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1177/0748233709348386</pub-id>
<pub-id pub-id-type="pmid">19793773</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-20-03611">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alassane-Kpembi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kolf-Clauw</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Abrami</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Abiola</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Oswald</surname>
<given-names>I.P.</given-names>
</name>
<name>
<surname>Puel</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>New insights into mycotoxin mixtures: The toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic</article-title>
<source/>Toxicol. Appl. Pharmacol.
          <year>2013</year>
<volume>272</volume>
<fpage>191</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2013.05.023</pub-id>
<pub-id pub-id-type="pmid">23735874</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-20-03611">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rzhetsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lyttle</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Environmental and state-level regulatory factors affect the incidence of autism and intellectual disability</article-title>
<source/>PLoS Comput. Biol.
          <year>2014</year>
<volume>10</volume>
<elocation-id>e1003518</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1003518</pub-id>
<pub-id pub-id-type="pmid">24625521</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-20-03611">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Wais</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders</article-title>
<source/>Eur. J. Neurosci.
          <year>2015</year>
<volume>42</volume>
<fpage>2742</fpage>
<lpage>2760</lpage>
<pub-id pub-id-type="doi">10.1111/ejn.13028</pub-id>
<pub-id pub-id-type="pmid">26215319</pub-id>
</element-citation>
</ref>
<ref id="B155-ijms-20-03611">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilburn</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Thrasher</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Immers</surname>
<given-names>N.B.</given-names>
</name>
</person-group>
<article-title>Do terbutaline- and mold-associated impairments of the brain and lung relate to autism?</article-title>
<source/>Toxicol. Ind. Health
          <year>2009</year>
<volume>25</volume>
<fpage>703</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="doi">10.1177/0748233709348391</pub-id>
<pub-id pub-id-type="pmid">19793774</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-20-03611">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Brera</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mezzelani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soricelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ciceri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moretti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Debegnach</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bonaglia</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Molteni</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of mycotoxins in the pathobiology of autism: A first evidence</article-title>
<source/>Nutr. Neurosci.
          <year>2019</year>
<volume>22</volume>
<fpage>132</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="pmid">28795659</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-20-03611">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tobel</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Antinori</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zurich</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Rosset</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Aschner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gluck</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scherl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monnet-Tschudi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype</article-title>
<source/>NeuroToxicology
          <year>2014</year>
<volume>44</volume>
<fpage>61</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2014.04.005</pub-id>
<pub-id pub-id-type="pmid">24792326</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-20-03611">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doebler</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Morse</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Ballough</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mesenteric mast cell degranulation in acute T-2 toxin poisoning</article-title>
<source/>Toxicol. Lett.
          <year>1992</year>
<volume>62</volume>
<fpage>33</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/0378-4274(92)90075-U</pub-id>
<pub-id pub-id-type="pmid">1509504</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-20-03611">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarom</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yagen</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Cutaneous injury by topical T-2 toxin: Involvement of microvessels and mast cells</article-title>
<source/>Toxicon
          <year>1987</year>
<volume>25</volume>
<fpage>167</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/0041-0101(87)90238-8</pub-id>
<pub-id pub-id-type="pmid">3576633</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-20-03611">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saluja</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Metz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maurer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Role and relevance of mast cells in fungal infections</article-title>
<source/>Front. Immunol.
          <year>2012</year>
<volume>3</volume>
<fpage>146</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2012.00146</pub-id>
<pub-id pub-id-type="pmid">22707950</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-20-03611">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Almkvist</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Effects of stress on learning and memory</article-title>
<source/>Concept Cogn. Emot. Behav.
          <year>2016</year>
<volume>10</volume>
<fpage>270</fpage>
<lpage>274</lpage>
</element-citation>
</ref>
<ref id="B162-ijms-20-03611">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Kavalioti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effect of stress on learning and motivation-relevance to autism spectrum disorder</article-title>
<source/>Int. J. Immunopath. Pharmacol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1177/2058738419856760</pub-id>
<pub-id pub-id-type="pmid">31220952</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-20-03611">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moscarello</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>LeDoux</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Active avoidance learning requires prefrontal suppression of amygdala-mediated defensive reactions</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>3815</fpage>
<lpage>3823</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2596-12.2013</pub-id>
<pub-id pub-id-type="pmid">23447593</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-20-03611">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Amygdala regulates risk of predation in rats foraging in a dynamic fear environment</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>21773</fpage>
<lpage>21777</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010079108</pub-id>
<pub-id pub-id-type="pmid">21115817</pub-id>
</element-citation>
</ref>
<ref id="B165-ijms-20-03611">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkmar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Woodbury-Smith</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>State</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder</article-title>
<source/>J. Am. Acad. Child. Adolesc. Psychiatry
          <year>2014</year>
<volume>53</volume>
<fpage>237</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2013.10.013</pub-id>
<pub-id pub-id-type="pmid">24472258</pub-id>
</element-citation>
</ref>
<ref id="B166-ijms-20-03611">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Canavera</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kleinpeter</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Maccubbin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Taga</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>The fears, phobias and anxieties of children with autism spectrum disorders and Down syndrome: Comparisons with developmentally and chronologically age matched children</article-title>
<source/>Child. Psychiatry Hum. Dev.
          <year>2005</year>
<volume>36</volume>
<fpage>3</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1007/s10578-004-3619-x</pub-id>
<pub-id pub-id-type="pmid">16049642</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-20-03611">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Philip</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Whalley</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Stanfield</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Sprengelmeyer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Lawrie</surname>
<given-names>S.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders</article-title>
<source/>Psychol. Med.
          <year>2010</year>
<volume>40</volume>
<fpage>1919</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291709992364</pub-id>
<pub-id pub-id-type="pmid">20102666</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-20-03611">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollocks</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Howlin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Khondoker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Differences in HPA-axis and heart rate responsiveness to psychosocial stress in children with autism spectrum disorders with and without co-morbid anxiety</article-title>
<source/>Psychoneuroendocrinology
          <year>2014</year>
<volume>46</volume>
<fpage>32</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.04.004</pub-id>
<pub-id pub-id-type="pmid">24882156</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-20-03611">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodgers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Glod</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McConachie</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The relationship between anxiety and repetitive behaviours in autism spectrum disorder</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2012</year>
<volume>42</volume>
<fpage>2404</fpage>
<lpage>2409</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-012-1531-y</pub-id>
<pub-id pub-id-type="pmid">22527704</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-20-03611">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steensel</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Bogels</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis</article-title>
<source/>Clin. Child. Fam. Psychol. Rev.
          <year>2011</year>
<volume>14</volume>
<fpage>302</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1007/s10567-011-0097-0</pub-id>
<pub-id pub-id-type="pmid">21735077</pub-id>
</element-citation>
</ref>
<ref id="B171-ijms-20-03611">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spratt</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Hatcher</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Meekins</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Furlanetto</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Enhanced cortisol response to stress in children in autism</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2012</year>
<volume>42</volume>
<fpage>75</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-011-1214-0</pub-id>
<pub-id pub-id-type="pmid">21424864</pub-id>
</element-citation>
</ref>
<ref id="B172-ijms-20-03611">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Drumm</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pla</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Tanel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Investigating the autonomic nervous system response to anxiety in children with autism spectrum disorders</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>59730</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059730</pub-id>
<pub-id pub-id-type="pmid">23577072</pub-id>
</element-citation>
</ref>
<ref id="B173-ijms-20-03611">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacKinnon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kingsbury</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mahedy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Colman</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>The Association Between Prenatal Stress and Externalizing Symptoms in Childhood: Evidence From the Avon Longitudinal Study of Parents and Children</article-title>
<source/>Biol. Psychiatry
          <year>2018</year>
<volume>83</volume>
<fpage>100</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.07.010</pub-id>
<pub-id pub-id-type="pmid">28893381</pub-id>
</element-citation>
</ref>
<ref id="B174-ijms-20-03611">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beversdorf</surname>
<given-names>D.Q.</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Hillier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Nordgren</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Nagaraja</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Cooley</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Gaelic</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Timing of prenatal stressors and autism</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2005</year>
<volume>35</volume>
<fpage>471</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-005-5037-8</pub-id>
<pub-id pub-id-type="pmid">16134032</pub-id>
</element-citation>
</ref>
<ref id="B175-ijms-20-03611">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronald</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pennell</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Whitehouse</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Prenatal maternal stress associated with ADHD and autistic traits in early childhood</article-title>
<source/>Front. Psychol.
          <year>2010</year>
<volume>1</volume>
<fpage>223</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyg.2010.00223</pub-id>
<pub-id pub-id-type="pmid">21833278</pub-id>
</element-citation>
</ref>
<ref id="B176-ijms-20-03611">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crafa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Warfa</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Maternal migration and autism risk: Systematic analysis</article-title>
<source/>Int. Rev. Psychiatry
          <year>2015</year>
<volume>27</volume>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.3109/09540261.2014.995601</pub-id>
<pub-id pub-id-type="pmid">25738316</pub-id>
</element-citation>
</ref>
<ref id="B177-ijms-20-03611">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simcock</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kildea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Elgbeili</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Laplante</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Cobham</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Prenatal maternal stress shapes children’s theory of mind: The QF2011 Queensland Flood Study</article-title>
<source/>J. Dev. Orig. Health Dis.
          <year>2017</year>
<volume>8</volume>
<fpage>483</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1017/S2040174417000186</pub-id>
<pub-id pub-id-type="pmid">28337952</pub-id>
</element-citation>
</ref>
<ref id="B178-ijms-20-03611">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babenko</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kovalchuk</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Metz</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2015</year>
<volume>48</volume>
<fpage>70</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.11.013</pub-id>
<pub-id pub-id-type="pmid">25464029</pub-id>
</element-citation>
</ref>
<ref id="B179-ijms-20-03611">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tordjman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Somogyi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Coulon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kermarrec</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bronsard</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bonnot</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Weismann-Arcache</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Botbol</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lauth</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environment interactions in autism spectrum disorders: Role of epigenetic mechanisms</article-title>
<source/>Front. Psychiatry
          <year>2014</year>
<volume>5</volume>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00053</pub-id>
<pub-id pub-id-type="pmid">25136320</pub-id>
</element-citation>
</ref>
<ref id="B180-ijms-20-03611">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedersen</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Rozing</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brunsgaard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meincke</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Prenatal and early postnatal stress and later life inflammation</article-title>
<source/>Psychoneuroendocrinology
          <year>2018</year>
<volume>88</volume>
<fpage>158</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2017.12.014</pub-id>
<pub-id pub-id-type="pmid">29291495</pub-id>
</element-citation>
</ref>
<ref id="B181-ijms-20-03611">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>The neuropathology of the autism spectrum disorders: What have we learned?</article-title>
<source/>Novartis. Found. Symp.
          <year>2003</year>
<volume>251</volume>
<fpage>112</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">14521190</pub-id>
</element-citation>
</ref>
<ref id="B182-ijms-20-03611">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bliss-Moreau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moadab</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Santistevan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>The effects of neonatal amygdala or hippocampus lesions on adult social behavior</article-title>
<source/>Behav. Brain Res.
          <year>2017</year>
<volume>322</volume>
<fpage>123</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2016.11.052</pub-id>
<pub-id pub-id-type="pmid">28017854</pub-id>
</element-citation>
</ref>
<ref id="B183-ijms-20-03611">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bondarenko</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hodgson</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Nalivaiko</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Amygdala mediates respiratory responses to sudden arousing stimuli and to restraint stress in rats</article-title>
<source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
          <year>2014</year>
<volume>306</volume>
<fpage>951</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.00528.2013</pub-id>
<pub-id pub-id-type="pmid">24740655</pub-id>
</element-citation>
</ref>
<ref id="B184-ijms-20-03611">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>The amygdala and autism: Implications from non-human primate studies</article-title>
<source/>Genes. Brain Behav.
          <year>2003</year>
<volume>2</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00043.x</pub-id>
<pub-id pub-id-type="pmid">14606694</pub-id>
</element-citation>
</ref>
<ref id="B185-ijms-20-03611">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Lavenex</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Capitanio</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>The development of mother-infant interactions after neonatal amygdala lesions in rhesus monkeys</article-title>
<source/>J. Neurosci.
          <year>2004</year>
<volume>24</volume>
<fpage>711</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3263-03.2004</pub-id>
<pub-id pub-id-type="pmid">14736857</pub-id>
</element-citation>
</ref>
<ref id="B186-ijms-20-03611">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avino</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Barger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Neuron numbers increase in the human amygdala from birth to adulthood, but not in autism</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>3710</fpage>
<lpage>3715</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1801912115</pub-id>
<pub-id pub-id-type="pmid">29559529</pub-id>
</element-citation>
</ref>
<ref id="B187-ijms-20-03611">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
</person-group>
<article-title>Amygdala activity, fear, and anxiety: Modulation by stress</article-title>
<source/>Biol. Psychiatry
          <year>2010</year>
<volume>67</volume>
<fpage>1117</fpage>
<lpage>1119</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.04.027</pub-id>
<pub-id pub-id-type="pmid">20525501</pub-id>
</element-citation>
</ref>
<ref id="B188-ijms-20-03611">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bliss-Moreau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Neonatal amygdala lesions result in globally blunted affect in adult rhesus macaques</article-title>
<source/>Behav. Neurosci.
          <year>2011</year>
<volume>125</volume>
<fpage>848</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1037/a0025757</pub-id>
<pub-id pub-id-type="pmid">21988521</pub-id>
</element-citation>
</ref>
<ref id="B189-ijms-20-03611">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bliss-Moreau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Toscano</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Neonatal amygdala lesions alter responsiveness to objects in juvenile macaques</article-title>
<source/>Neuroscience
          <year>2011</year>
<volume>178</volume>
<fpage>123</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.12.038</pub-id>
<pub-id pub-id-type="pmid">21215794</pub-id>
</element-citation>
</ref>
<ref id="B190-ijms-20-03611">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.G.</given-names>
</name>
</person-group>
<article-title>Corticotropin releasing factor and substance P mediate the nucleus amygdaloideus centralis-nucleus ventromedialis-nucleus dorsomedialis pressor system</article-title>
<source/>Brain Res.
          <year>1999</year>
<volume>842</volume>
<fpage>392</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(99)01862-4</pub-id>
<pub-id pub-id-type="pmid">10526135</pub-id>
</element-citation>
</ref>
<ref id="B191-ijms-20-03611">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almehmadi</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Increased expression of miR-155p5 in amygdala of children with Autism Spectrum Disorder</article-title>
<source/>Autism. Res.
          <year>2019</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="B192-ijms-20-03611">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Hubbard</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dar</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sipes</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Predator odor-induced conditioned fear involves the basolateral and medial amygdala</article-title>
<source/>Behav. Neurosci.
          <year>2007</year>
<volume>121</volume>
<fpage>100</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.121.1.100</pub-id>
<pub-id pub-id-type="pmid">17324054</pub-id>
</element-citation>
</ref>
<ref id="B193-ijms-20-03611">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Parkes</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Killcross</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>The basolateral amygdala is critical for learning about neutral stimuli in the presence of danger, and the perirhinal cortex is critical in the absence of danger</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>13112</fpage>
<lpage>13125</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1998-13.2013</pub-id>
<pub-id pub-id-type="pmid">23926265</pub-id>
</element-citation>
</ref>
<ref id="B194-ijms-20-03611">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Truitt</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Sajdyk</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Oberlin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McDougle</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Shekhar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>From anxiety to autism: Spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats</article-title>
<source/>Psychopharmacology
          <year>2007</year>
<volume>191</volume>
<fpage>107</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-006-0674-y</pub-id>
<pub-id pub-id-type="pmid">17277936</pub-id>
</element-citation>
</ref>
<ref id="B195-ijms-20-03611">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Letourneau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seretakis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors</article-title>
<source/>J. Pharmacol. Exp. Ther.
          <year>1999</year>
<volume>288</volume>
<fpage>1349</fpage>
<lpage>1356</lpage>
<pub-id pub-id-type="pmid">10027877</pub-id>
</element-citation>
</ref>
<ref id="B196-ijms-20-03611">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sismanopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Critchfield</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Neurotensin and CRH interactions augment human mast cell activation</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>48934</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0048934</pub-id>
<pub-id pub-id-type="pmid">23155429</pub-id>
</element-citation>
</ref>
<ref id="B197-ijms-20-03611">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Angelidou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miniati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sismanopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vasiadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kalogeromitros</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells</article-title>
<source/>J. Invest. Dermatol.
          <year>2012</year>
<volume>132</volume>
<fpage>324</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2011.334</pub-id>
<pub-id pub-id-type="pmid">22089831</pub-id>
</element-citation>
</ref>
<ref id="B198-ijms-20-03611">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Lytinas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kandere-Grzybowska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Madhappan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Athanassiou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells</article-title>
<source/>Endocrinology
          <year>2004</year>
<volume>145</volume>
<fpage>43</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1210/en.2003-0805</pub-id>
<pub-id pub-id-type="pmid">14576187</pub-id>
</element-citation>
</ref>
<ref id="B199-ijms-20-03611">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Donelan</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Papadopoulou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kempuraj</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Mast cells as targets of corticotropin-releasing factor and related peptides</article-title>
<source/>Trends Pharmacol. Sci.
          <year>2004</year>
<volume>25</volume>
<fpage>563</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2004.09.007</pub-id>
<pub-id pub-id-type="pmid">15491778</pub-id>
</element-citation>
</ref>
<ref id="B200-ijms-20-03611">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin</article-title>
<source/>J. Neuroinflam.
          <year>2012</year>
<volume>9</volume>
<fpage>85</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-9-85</pub-id>
<pub-id pub-id-type="pmid">22559745</pub-id>
</element-citation>
</ref>
<ref id="B201-ijms-20-03611">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chrousos</surname>
<given-names>G.P.</given-names>
</name>
</person-group>
<article-title>The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation</article-title>
<source/>N. Engl. J. Med.
          <year>1995</year>
<volume>332</volume>
<fpage>1351</fpage>
<lpage>1362</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199505183322008</pub-id>
<pub-id pub-id-type="pmid">7715646</pub-id>
</element-citation>
</ref>
<ref id="B202-ijms-20-03611">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>S.F.</given-names>
</name>
</person-group>
<article-title>Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disorders</article-title>
<source/>Neurobiol. Stress
          <year>2016</year>
<volume>4</volume>
<fpage>62</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.ynstr.2015.12.004</pub-id>
<pub-id pub-id-type="pmid">27981190</pub-id>
</element-citation>
</ref>
<ref id="B203-ijms-20-03611">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Amidfar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <year>2018</year>
<volume>91</volume>
<fpage>103</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.06.008</pub-id>
<pub-id pub-id-type="pmid">29932946</pub-id>
</element-citation>
</ref>
<ref id="B204-ijms-20-03611">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Missig</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Finger</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Landino</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Mokler</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Manasian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC-Amygdala Circuits</article-title>
<source/>J. Neurosci.
          <year>2018</year>
<volume>38</volume>
<fpage>3358</fpage>
<lpage>3372</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3642-17.2018</pub-id>
<pub-id pub-id-type="pmid">29491010</pub-id>
</element-citation>
</ref>
<ref id="B205-ijms-20-03611">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michopoulos</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Jovanovic</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond</article-title>
<source/>Neuropsychopharmacology
          <year>2017</year>
<volume>42</volume>
<fpage>254</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2016.146</pub-id>
<pub-id pub-id-type="pmid">27510423</pub-id>
</element-citation>
</ref>
<ref id="B206-ijms-20-03611">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrlich</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Rainnie</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Prenatal Stress Alters the Development of Socioemotional Behavior and Amygdala Neuron Excitability in Rats</article-title>
<source/>Neuropsychopharmacology
          <year>2015</year>
<volume>40</volume>
<fpage>2135</fpage>
<lpage>2145</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2015.55</pub-id>
<pub-id pub-id-type="pmid">25716930</pub-id>
</element-citation>
</ref>
<ref id="B207-ijms-20-03611">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Leshem</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gaisler-Salomon</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Prereproductive stress to female rats alters corticotropin releasing factor type 1 expression in ova and behavior and brain corticotropin releasing factor type 1 expression in offspring</article-title>
<source/>Biol. Psychiatry
          <year>2013</year>
<volume>74</volume>
<fpage>680</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.04.014</pub-id>
<pub-id pub-id-type="pmid">23726318</pub-id>
</element-citation>
</ref>
<ref id="B208-ijms-20-03611">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercum</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Benison</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>Z.Z.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kornreich</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grabenstatter</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Dudek</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>D.S.</given-names>
</name>
</person-group>
<article-title>Maternal Stress Combined with Terbutaline Leads to Comorbid Autistic-Like Behavior and Epilepsy in a Rat Model</article-title>
<source/>J. Neurosci.
          <year>2015</year>
<volume>35</volume>
<fpage>15894</fpage>
<lpage>15902</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2803-15.2015</pub-id>
<pub-id pub-id-type="pmid">26631470</pub-id>
</element-citation>
</ref>
<ref id="B209-ijms-20-03611">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tottenham</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>A review of adversity, the amygdala and the hippocampus: A consideration of developmental timing</article-title>
<source/>Front. Hum. Neurosci.
          <year>2009</year>
<volume>3</volume>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.3389/neuro.09.068.2009</pub-id>
<pub-id pub-id-type="pmid">20161700</pub-id>
</element-citation>
</ref>
<ref id="B210-ijms-20-03611">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bilbo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Hanamsagar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>P.K.</given-names>
</name>
</person-group>
<article-title>Beyond infection–Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders</article-title>
<source/>Exp. Neurol.
          <year>2018</year>
<volume>299</volume>
<fpage>241</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.07.002</pub-id>
<pub-id pub-id-type="pmid">28698032</pub-id>
</element-citation>
</ref>
<ref id="B211-ijms-20-03611">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barreau</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Salvador-Cartier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Houdeau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bueno</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fioramonti</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats</article-title>
<source/>Gut
          <year>2008</year>
<volume>57</volume>
<fpage>582</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1136/gut.2007.126680</pub-id>
<pub-id pub-id-type="pmid">18194988</pub-id>
</element-citation>
</ref>
<ref id="B212-ijms-20-03611">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Karalis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice</article-title>
<source/>Cardiovasc. Res.
          <year>2003</year>
<volume>59</volume>
<fpage>241</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/S0008-6363(03)00340-7</pub-id>
<pub-id pub-id-type="pmid">12829195</pub-id>
</element-citation>
</ref>
<ref id="B213-ijms-20-03611">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation</article-title>
<source/>Mol. Neurobiol.
          <year>2017</year>
<volume>54</volume>
<fpage>997</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-016-9720-x</pub-id>
<pub-id pub-id-type="pmid">26797518</pub-id>
</element-citation>
</ref>
<ref id="B214-ijms-20-03611">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garay</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development</article-title>
<source/>Brain Behav. Immun.
          <year>2013</year>
<volume>31</volume>
<fpage>54</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2012.07.008</pub-id>
<pub-id pub-id-type="pmid">22841693</pub-id>
</element-citation>
</ref>
<ref id="B215-ijms-20-03611">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Polesel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richetto</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Weber-Stadlbauer</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Mouse models of maternal immune activation: Mind your caging system!</article-title>
<source/>Brain Behav. Immun.
          <year>2018</year>
<volume>73</volume>
<fpage>643</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2018.07.014</pub-id>
<pub-id pub-id-type="pmid">30026057</pub-id>
</element-citation>
</ref>
<ref id="B216-ijms-20-03611">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kentner</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Bilbo</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Pletnikov</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Maternal immune activation: Reporting guidelines to improve the rigor, reproducibility, and transparency of the model</article-title>
<source/>Neuropsychopharmacology
          <year>2019</year>
<volume>44</volume>
<fpage>245</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1038/s41386-018-0185-7</pub-id>
<pub-id pub-id-type="pmid">30188509</pub-id>
</element-citation>
</ref>
<ref id="B217-ijms-20-03611">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Kavalioti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Stress, inflammation and natural treatments</article-title>
<source/>J. Biol. Regul. Homeost. Agents
          <year>2018</year>
<volume>32</volume>
<fpage>1345</fpage>
<lpage>1347</lpage>
<pub-id pub-id-type="pmid">30574737</pub-id>
</element-citation>
</ref>
<ref id="B218-ijms-20-03611">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>2580</fpage>
<lpage>2585</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0707854105</pub-id>
<pub-id pub-id-type="pmid">18250339</pub-id>
</element-citation>
</ref>
<ref id="B219-ijms-20-03611">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taracanova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tsilioni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Norwitz</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Leeman</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Theoharides</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Substance P and IL-33 administered together stimulate a marked secretion of IL-1beta from human mast cells, inhibited by methoxyluteolin</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>9381</fpage>
<lpage>9390</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1810133115</pub-id>
<pub-id pub-id-type="pmid">30232261</pub-id>
</element-citation>
</ref>
<ref id="B220-ijms-20-03611">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>7534</fpage>
<lpage>7539</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0802865105</pub-id>
<pub-id pub-id-type="pmid">18490655</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-03611-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Diagrammatic representation of how stress in patients with Autism Spectrum Disorder (ASD) leads to focal inflammation in the amygdala. Stress stimulates release of mast cell-derived molecules in amygdala that activate microglia that further release pro-inflammatory molecules contributing to local inflammation and dysregulated neuronal pruning and connectivity, thus leading to symptoms of ASD.</p>
</caption>
<graphic xlink:href="ijms-20-03611-g001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>